Dec 31 (Reuters) - A federal judge in Texas on Saturday
issued a court order barring enforcement of an Obama
administration policy seeking to extend anti-discrimination
protections under the Affordable Care Act to transgender health
and abortion-related services.
Read more
Saturday, December 31, 2016
Braeburn Pharmaceuticals files for IPO
Dec 30 (Reuters) - Braeburn Pharmaceuticals Inc filed with
U.S. regulators on Friday to raise up to $150 million in an
initial public offering, seven months after its implant to treat
opioid addiction was approved in the United States.
Read more
U.S. regulators on Friday to raise up to $150 million in an
initial public offering, seven months after its implant to treat
opioid addiction was approved in the United States.
Read more
Friday, December 30, 2016
BRIEF-Vitality Products Inc reports Q3 net loss per $0.00/shr
* Vitality Products Inc says for three months ended October
31, 2016 net loss per share of $0.00
Source text for Eikon:
Further company coverage:
Read more
31, 2016 net loss per share of $0.00
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Novavax Inc files for mixed shelf of upto $125 mln - SEC filing
* Novavax Inc - files for mixed shelf of upto $125 million -
SEC filing
Source text: (http://bit.ly/2iyJ7uW)
Further company coverage:
Read more
SEC filing
Source text: (http://bit.ly/2iyJ7uW)
Further company coverage:
Read more
BRIEF-Rewalk Robotics says drew down $8 mln under loan agreement with Kreos Capital
* Rewalk Robotics - in connection with $8 million drawdown,
on Dec 28, increased amount of warrant issued to Kreos on Dec
30, 2015 from $1.15 million to $1.61 million
Read more
on Dec 28, increased amount of warrant issued to Kreos on Dec
30, 2015 from $1.15 million to $1.61 million
Read more
BRIEF-Axovant Sciences files for mixed shelf of up to $750 mln - SEC filing
* Files for mixed shelf of up to $750 million - SEC filing
Source text: (http://bit.ly/2iNwLhV)
Further company coverage:
Read more
Source text: (http://bit.ly/2iNwLhV)
Further company coverage:
Read more
UPDATE 1-Obama to meet lawmakers in attempt to protect health law
WASHINGTON, Dec 30 (Reuters) - President Barack Obama plans
to meet Democratic lawmakers in Congress next week to discuss
how to protect his signature healthcare law from Republican
efforts to dismantle it, a White House official said on Friday.
Read more
to meet Democratic lawmakers in Congress next week to discuss
how to protect his signature healthcare law from Republican
efforts to dismantle it, a White House official said on Friday.
Read more
BRIEF-MiMedx says files lawsuits against two additional former sales employees for breach of contractual obligations
* MiMedx files lawsuits against two additional former sales
employees for breach of contractual obligations
Read more
employees for breach of contractual obligations
Read more
Ireland confirms bird flu case, carrying out tests
DUBLIN, Dec 30 (Reuters) - Ireland has found the H5N8 bird
flu strain in a wild duck in the south eastern town of Wexford,
the agriculture department said on Friday.
Read more
flu strain in a wild duck in the south eastern town of Wexford,
the agriculture department said on Friday.
Read more
Bulgaria to cull more poultry as bird flu outbreak spreads
SOFIA, Dec 30 (Reuters) - Bulgaria will cull more ducks and
chickens in the southern Plovdiv region and has banned fishing
in lakes and wetlands inhabited by wild migrating birds, the
food safety agency said on Friday, as it struggles to contain a
bird flu outbreak.
Read more
chickens in the southern Plovdiv region and has banned fishing
in lakes and wetlands inhabited by wild migrating birds, the
food safety agency said on Friday, as it struggles to contain a
bird flu outbreak.
Read more
UPDATE 1-Growth hormone deficiency drug from OPKO and Pfizer fails study
Dec 30 (Reuters) - OPKO Health Inc said its
experimental drug for growth hormone deficiency (GHD) in adults
failed to provide a statistically significant benefit over a
placebo in a late-stage study, sending its shares down 14
percent in early trading.
Read more
experimental drug for growth hormone deficiency (GHD) in adults
failed to provide a statistically significant benefit over a
placebo in a late-stage study, sending its shares down 14
percent in early trading.
Read more
Bill Gates warns world "vulnerable" to deadly epidemic in next decade
LONDON, Dec 30 (Thomson Reuters Foundation) - Billionaire
philanthropist Bill Gates warned on Friday that the world was
vulnerable to a deadly epidemic of an illness like flu, with the
recent Ebola and Zika outbreaks underlining weaknesses in global
efforts to tackle health crises swiftly.
Read more
philanthropist Bill Gates warned on Friday that the world was
vulnerable to a deadly epidemic of an illness like flu, with the
recent Ebola and Zika outbreaks underlining weaknesses in global
efforts to tackle health crises swiftly.
Read more
BRIEF-Triple-S Management enters into a credit agreement pursuant to which it borrowed approximately $35.5 mln
* Term loan a matures in October 2023 and term loan B and
term loan C mature in January 2024
Read more
term loan C mature in January 2024
Read more
Growth hormone deficiency drug from OPKO and Pfizer fails study
Dec 30 (Reuters) - OPKO Health Inc said on Friday
its experimental drug for growth hormone deficiency did not
provide a statistically significant benefit over a placebo in a
late-stage study.
Read more
its experimental drug for growth hormone deficiency did not
provide a statistically significant benefit over a placebo in a
late-stage study.
Read more
BRIEF-Beigene announces first patient dosing in China phase I trial with investigational anti-pd-1 monoclonal antibody bgb-a317
* Beigene ltd- dosing of first patient in phase i clinical
trial of bgb-a317 in mainland chinese patients with advanced
solid tumors
Read more
trial of bgb-a317 in mainland chinese patients with advanced
solid tumors
Read more
BRIEF-Cachet Pharma to buy stakes in medical instrument firms for 848.1 mln yuan
* Says it plans to buy stakes in 12 medical instrument firms
for a combined 848.1 million yuan ($122.17 million) via share
issue
Read more
for a combined 848.1 million yuan ($122.17 million) via share
issue
Read more
Russia reports two outbreaks of bird flu
MOSCOW, Dec 30 (Reuters) - Russia has registered outbreaks
of bird flu on two poultry farms in its southern regions of
Krasnodar and Rostov, the agriculture safety watchdog
Rosselkhoznadzor said in two statements on Friday.
Read more
of bird flu on two poultry farms in its southern regions of
Krasnodar and Rostov, the agriculture safety watchdog
Rosselkhoznadzor said in two statements on Friday.
Read more
BRIEF-China Grand Automotive Services unit to sell 70 pct stake in real estate company 88.5 mln yuan to investment company
* Says its subsidiary will sell 70 percent stake in a
Wuxi-based real estate company at 88.5 million yuan to a
Guigang-based investment company
Read more
Wuxi-based real estate company at 88.5 million yuan to a
Guigang-based investment company
Read more
BRIEF-Golden Meditech to sell its equity interest in China
* Golden Meditech Holdings Ltd - as part of transaction,
golden meditech agrees to give three years' performance
guarantee of ccbc in favour of purchaser
Read more
golden meditech agrees to give three years' performance
guarantee of ccbc in favour of purchaser
Read more
BRIEF-Traditional Therapy Clinics acquires new property for A$18.46 mln
* New head office building costs RMB92.53 million, which
equates to aud18.46 million at an exchange rate of 5.01
(aud:rmb)
Read more
equates to aud18.46 million at an exchange rate of 5.01
(aud:rmb)
Read more
UPDATE 1-China bird flu has not spread, no impact on poultry market - govt
BEIJING, Dec 30 (Reuters) - China's Ministry of Agriculture
said on Friday the recent outbreaks of bird flu have been
handled in a "timely and effective" manner without spreading and
have not affected chicken products or prices.
Read more
said on Friday the recent outbreaks of bird flu have been
handled in a "timely and effective" manner without spreading and
have not affected chicken products or prices.
Read more
BRIEF-Glycorex Transplantation: New patent granted in USA
* New patent granted in USA
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Thursday, December 29, 2016
UPDATE 1-Elekta says wins order in Stockholm, initially worth SEK 350 mln
* Says Stockholm county council, New Karolinska Solna and
Elekta sign a 13-year collaboration agreement to advance cancer
care
Read more
Elekta sign a 13-year collaboration agreement to advance cancer
care
Read more
Swiss stocks - Factors to watch on Friday
ZURICH, Dec 30 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Friday.
Read more
main factors expected to affect Swiss stocks on Friday.
Read more
Shanghai confirms new human case of H7N9 bird flu - Xinhua
BEIJING, Dec 30 (Reuters) - Shanghai's health authority has
confirmed a new human case of infection by the H7N9 strain of
avian influenza, the state-owned news agency Xinhua said on
Friday.
Read more
confirmed a new human case of infection by the H7N9 strain of
avian influenza, the state-owned news agency Xinhua said on
Friday.
Read more
BRIEF-Lepu Medical Technology Beijing raises 719 mln yuan via private placement
Dec 30 (Reuters) - Lepu Medical Technology Beijing Co Ltd
:
* Says it issued 38,082,627 shares via private placement
* Says it raised about 719 million yuan in total
Source text in Chinese: https://goo.gl/r3aNAa
Further company Coverage:
(Beijing Headline News)
Read more
BRIEF-Legochem Biosciences to raise 5 bln won via rights issue
* Says it will issue 1 million shares via rights issue to
raise 5 billion won, at 5,000 won/share
Read more
raise 5 billion won, at 5,000 won/share
Read more
BRIEF-PharmAust announces capital raising
Dec 30 (Reuters) - PharmAust Ltd
* Pharmaust raises a further $1.56 mln
*
Source text for Eikon:
Further company coverage:
Read more
Bankers cautious on outlook for global equity deals after 2016 slide
LONDON, Dec 30 (Reuters) - Global equity raising fell by
more than a quarter in 2016, data showed on Friday, hit by
geopolitical shocks and a string of failed initial public
offerings (IPOs), with the outlook for 2017 looking shaky.
Read more
more than a quarter in 2016, data showed on Friday, hit by
geopolitical shocks and a string of failed initial public
offerings (IPOs), with the outlook for 2017 looking shaky.
Read more
BRIEF-Mast Therapeutics says expects restructuring costs of about $0.4 mln
* Mast Therapeutics Inc - company expects all restructuring
costs relating to workforce reduction to be paid in Q4 of 2016
or Q1 of 2017
Read more
costs relating to workforce reduction to be paid in Q4 of 2016
or Q1 of 2017
Read more
Britain avoids M&A collapse as foreign buyers go Brexit bargain hunting
LONDON, Dec 30 (Reuters) - Britain avoided a collapse in
mergers and acquisitions activity after the shock Brexit vote as
foreign companies used sterling's spectacular devaluation
against the U.S. dollar to snap up British companies, Thomson
Reuters data shows.
Read more
mergers and acquisitions activity after the shock Brexit vote as
foreign companies used sterling's spectacular devaluation
against the U.S. dollar to snap up British companies, Thomson
Reuters data shows.
Read more
BRIEF-Actinogen Medical seeks trading halt
* requests that its securities be placed into an immediate
trading halt pending an announcement regarding actinogen
medical's application to FDA
Read more
trading halt pending an announcement regarding actinogen
medical's application to FDA
Read more
BRIEF-Innocoll receives refusal to file letter from U.S. FDA for xaracoll new drug application
* Innocoll Holdings - FDA indicated xaracoll should be
characterized as drug/device combination, which would require co
submit additional information
Read more
characterized as drug/device combination, which would require co
submit additional information
Read more
Deals of the day-Mergers and acquisitions
Dec 29 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Thursday:
Read more
and disposals were reported by 2100 GMT on Thursday:
Read more
BRIEF-Mylan launches generic Concerta tablets
* Mylan - U.S. launch of methylphenidate hydrochloride
extended-release tablets usp, 18 mg, 27 mg, 36 mg and 54 mg,
generic version of Janssen's Concerta tablets
Source text for Eikon:
Further company coverage:
Read more
extended-release tablets usp, 18 mg, 27 mg, 36 mg and 54 mg,
generic version of Janssen's Concerta tablets
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Stonepine Capital Management reports 6.4 pct passive stake in Ophthotech Corp
* Stonepine Capital Management Llc - reports 6.4 percent
passive stake in Ophthotech Corp as of Dec 19 - SEC Filing
Source text - http://bit.ly/2hA5aEu
Further company coverage:
Read more
passive stake in Ophthotech Corp as of Dec 19 - SEC Filing
Source text - http://bit.ly/2hA5aEu
Further company coverage:
Read more
LPC: US syndicated lending flat in 2016 after late-year spurt
NEW YORK, Dec 29 (Reuters) - A fourth-quarter rush of
corporate buyouts and refinancing, as markets rallied on
prospects of looser financial regulations under a Trump
administration, pulled 2016 US syndicated lending volume up to
match the prior year's pace.
Read more
corporate buyouts and refinancing, as markets rallied on
prospects of looser financial regulations under a Trump
administration, pulled 2016 US syndicated lending volume up to
match the prior year's pace.
Read more
Fitch Affirms Community Health Systems at 'B'; Outlook Negative
(The following statement was released by the rating agency)
NEW YORK, December 29 (Fitch) Fitch Ratings has removed the
ratings of Community
Health Systems, Inc. (CHS) from Rating Watch Evolving and has
affirmed the
Issuer Default Rating (IDR) at 'B'. The Rating Outlook is
Negative. The ratings
apply to $15.5 billion of debt outstanding at Sept. 30, 2016. A
full list of
rating actions follows at the end of this release.
KEY RATING DRIVERS
Persistent Credit Profile Headwinds: The Negative Out
Read more
NEW YORK, December 29 (Fitch) Fitch Ratings has removed the
ratings of Community
Health Systems, Inc. (CHS) from Rating Watch Evolving and has
affirmed the
Issuer Default Rating (IDR) at 'B'. The Rating Outlook is
Negative. The ratings
apply to $15.5 billion of debt outstanding at Sept. 30, 2016. A
full list of
rating actions follows at the end of this release.
KEY RATING DRIVERS
Persistent Credit Profile Headwinds: The Negative Out
Read more
BRIEF-Endologix resumes shipments and procedures with AFX
* Endologix resumes shipments and procedures with AFX and
some sizes of AFX2
Source text for Eikon:
Further company coverage:
Read more
some sizes of AFX2
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Skyline Medical receives requested extension from NASDAQ panel
* Skyline Medical - NASDAQ hearings panel has granted
company's request for continued listing on NASDAQ pursuant to an
extension through April 11, 2017
Read more
company's request for continued listing on NASDAQ pursuant to an
extension through April 11, 2017
Read more
BRIEF-Mylan NV launches generic Cerebyx injection
* Mylan NV says U.S. launch of fosphenytoin sodium injection
USP
Source text for Eikon:
Further company coverage:
Read more
USP
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Yunnan Baiyao's share trade to resume on Dec 30
* Says share trade to resume on December 30 after
controlling shareholder has received 25.4 billion yuan ($3.65
billion)investment from Newhuadu Industrial Group
Read more
controlling shareholder has received 25.4 billion yuan ($3.65
billion)investment from Newhuadu Industrial Group
Read more
BRIEF-Crown Bioscience International unit to set up unit in U.S and new unit to form strategic cooperation with New Iberia Research Center
* Says its subsidiary Crown Bioscience Inc. plans to set up
a sub-subsidiary named Crown Bioscience Louisiana. in U.S
Read more
a sub-subsidiary named Crown Bioscience Louisiana. in U.S
Read more
Wednesday, December 28, 2016
Swiss stocks - Factors to watch on Dec 29
ZURICH, Dec 29 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.2 percent lower at 8,237 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.2 percent lower at 8,237 points on Thursday,
according to premarket indications by bank Julius Baer
.
Read more
BRIEF-Argenx publishes seminal data supporting therapeutic potential of ARGX-110
* Argenx announces publication of seminal data supporting the therapeutic potential of
ARGX-110 for acute myeloid leukemia in the Journal of Experimental Medicine
Read more
ARGX-110 for acute myeloid leukemia in the Journal of Experimental Medicine
Read more
BRIEF-Zhejiang Jiuzhou Pharmaceutical appoints Hua Lirong as chairman, Chen Zhihong as general manager
* Says Hua Dexuan resigned from chairman of the board, Hua
Lirong resigned from general manager
Read more
Lirong resigned from general manager
Read more
UPDATE 2-U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company
Boehringer Ingelheim agreed to divest five types of animal
health products to settle charges that a proposed asset swap
with Sanofi would harm competition, the U.S. Federal Trade
Commission said on Wednesday.
Read more
Boehringer Ingelheim agreed to divest five types of animal
health products to settle charges that a proposed asset swap
with Sanofi would harm competition, the U.S. Federal Trade
Commission said on Wednesday.
Read more
BRIEF-Beijing Beilu Pharmaceutical receives GMP certificate
* Says it received goods manufacture practice (GMP)
certificate from State Food and Drug Administration of Beijing
Read more
certificate from State Food and Drug Administration of Beijing
Read more
BRIEF-Alere provides update on Arriva Medical
* Arriva has filed an appeal with administrative law judge
(ALJ) at CMS seeking to reinstate Arriva's billing status
Read more
(ALJ) at CMS seeking to reinstate Arriva's billing status
Read more
BRIEF-Provectus Biopharmaceuticals terminates Peter Culpepper as interim CEO and COO
* Provectus Biopharmaceuticals terminates Peter Culpepper as
interim CEO and COO
Source text for Eikon:
Further company coverage:
Read more
interim CEO and COO
Source text for Eikon:
Further company coverage:
Read more
UPDATE 2-Burger King, Tim Hortons to curb antibiotics used in chicken
CHICAGO/LOS ANGELES, Dec 28 (Reuters) - Restaurant chains
Burger King and Tim Hortons plan to switch to chicken raised
without antibiotics considered "critically important" to human
medicine, their owner said on Wednesday, making it the latest
company to ditch the drugs over health concerns.
Read more
Burger King and Tim Hortons plan to switch to chicken raised
without antibiotics considered "critically important" to human
medicine, their owner said on Wednesday, making it the latest
company to ditch the drugs over health concerns.
Read more
BRIEF-Regeneus announces collaboration with AGC Asahi Glass
* Regeneus collaborates with agc asahi for exclusive
manufacture of progenza stem cell technology for Japanese market
Read more
manufacture of progenza stem cell technology for Japanese market
Read more
Deals of the day-Mergers and acquisitions
Dec 28 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Wednesday:
Read more
and disposals were reported by 2100 GMT on Wednesday:
Read more
REUTERS AMERICA NEWS PLAN FOR WEDNESDAY DEC 28
For latest stories search by Slug or Headline Keyword in
your CMS or Advanced Search in Media Express.
Read more
your CMS or Advanced Search in Media Express.
Read more
U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
WASHINGTON, Dec 28 (Reuters) - The U.S. Federal Trade
Commission said on Wednesday that German pharmaceutical company
Boehringer Ingelheim agreed to divest five types of animal
health products to settle FTC charges that a proposed asset swap
with Sanofi would harm competition.
Read more
Commission said on Wednesday that German pharmaceutical company
Boehringer Ingelheim agreed to divest five types of animal
health products to settle FTC charges that a proposed asset swap
with Sanofi would harm competition.
Read more
BRIEF-Bioporto expands its NGAL related patent portfolio
* Has entered into exclusive license agreement with Trustees of Columbia, University for
NGAL patents
Read more
NGAL patents
Read more
BRIEF-Immunocellular Therapeutics Ltd files for offering of up to $20 mln of common units
* Immunocellular Therapeutics Ltd - files for offering of up
to up to $20.0 million of common units, each consisting of share
of common stock, and warrant
Source text http://bit.ly/2iqqMjC
Further company coverage:
Read more
to up to $20.0 million of common units, each consisting of share
of common stock, and warrant
Source text http://bit.ly/2iqqMjC
Further company coverage:
Read more
BRIEF-Cadila Healthcare unit Zydus buys six brands from MSD
* Six brands acquired are Deca-Durabolin, Durabolin,
Sustanon, Multiload, Sicastat and Axeten
Read more
Sustanon, Multiload, Sicastat and Axeten
Read more
BRIEF-Blirt buys device for 629,000 zlotys to produce proteins
* Buys device and software for pilot production of proteins for 629,000 zlotys ($148,696)
gross
Read more
gross
Read more
BRIEF-Ascendance Biotechnology licenses the right to manufacture and sell cytiva cardiomyocytes
* Ascendance biotechnology licenses the right to
manufacture, market and sell cytiva cardiomyocytes
Read more
manufacture, market and sell cytiva cardiomyocytes
Read more
BRIEF-Concordia International says Beighton will retire from co's international segment president role
* Concordia International - effective january 1, 2017, john
beighton will retire from his current role as president of
company's international segment
Read more
beighton will retire from his current role as president of
company's international segment
Read more
BRIEF-Guangxi Wuzhou Zhongheng, unit plan to set up investment firm
* Says it and unit plan to invest 400 million yuan ($57.50
million) to set up investment firm
Read more
million) to set up investment firm
Read more
BRIEF-Jiangsu Lianhuan Pharma's chairman, general manager retire
* Says chairman Yao Xingtian, general manager Qian Ni resign
as they have reached retirement age
Read more
as they have reached retirement age
Read more
BRIEF-Chongqing Sanxia Paints sold shares in Beijing Beilu Pharma for 182.3 mln yuan
* Says it has sold 10 million shares in Beijing Beilu Pharma
for 182.3 million yuan ($26.21 million) on Dec 28
via block trade
Read more
for 182.3 million yuan ($26.21 million) on Dec 28
via block trade
Read more
BRIEF-Zhuhai Hokai Medical Instruments signs hospital construction contract
* Says it signs hospital construction contract with
investment of 250 million yuan ($35.94 million)
Read more
investment of 250 million yuan ($35.94 million)
Read more
BRIEF-1nkemia invests 100,000 euros in Arkyne Technologies
* Its unit IUCT Empren s.l. has invested 100,000 euros in the clean-tech company Arkyne
Technologies s.l. , reaching a stake of 4 percent
Read more
Technologies s.l. , reaching a stake of 4 percent
Read more
UPDATE 1-Now China's Wuxi to suspend poultry trade amid bird flu fears
BEIJING, Dec 28 (Reuters) - The eastern Chinese city of Wuxi
will suspend poultry trade from Thursday amid fears about bird
flu, becoming the second city in Jiangsu province to halt live
poultry markets, it said.
Read more
will suspend poultry trade from Thursday amid fears about bird
flu, becoming the second city in Jiangsu province to halt live
poultry markets, it said.
Read more
Tuesday, December 27, 2016
China's Wuxi city to suspends poultry trade on avian flu concerns
BEIJING, Dec 28 (Reuters) - Wuxi city in China's eastern
Jiangsu province will suspend poultry trading starting from Dec.
29 amid avian flu concerns, the city's information office
announced on Wednesday on its official microblog.
Read more
Jiangsu province will suspend poultry trading starting from Dec.
29 amid avian flu concerns, the city's information office
announced on Wednesday on its official microblog.
Read more
BRIEF-Wonik to buy stake in agriculture unit for 659.4 mln won
* Says it will buy 65,935 shares of its subsidiary, an
agriculture firm, for 659.4 million won
Read more
agriculture firm, for 659.4 million won
Read more
BRIEF-Ose immunotherapeutics signs license agreement with Servier
* Grants Servier license option on exclusive worldwide
rights for development and commercialization of Effi-7
Read more
rights for development and commercialization of Effi-7
Read more
BRIEF-UMN Pharma announces exercise of options
* Says 200,000 units of its 20th series options were
exercised to 200,000 shares of its common stock on Dec. 28
Read more
exercised to 200,000 shares of its common stock on Dec. 28
Read more
BRIEF-Zhejiang Nhu's controlling shareholder gets exchange's approval for exchangeable bonds issue
* Says its controlling shareholder gets Shenzhen Stock
Exchange's approval to issue up to 2.0 billion yuan ($287.60
million) exchangeable bonds
Read more
Exchange's approval to issue up to 2.0 billion yuan ($287.60
million) exchangeable bonds
Read more
BRIEF-Tibet Rhodiola Pharmaceutical Holding receives industrial development support funds of 17.4 mln yuan
* Says it received industrial development support funds of
17.4 million yuan from Finance Bureau of Shannan
Read more
17.4 million yuan from Finance Bureau of Shannan
Read more
INSIGHT-Serial testers and cursory checks: India's flawed generic drug trials business
HYDERABAD, Dec 28 (Reuters) - Vasudeva Prakash left his job
as a mechanic in Hyderabad three years ago for what he calls a
more lucrative career: taking part in clinical trials on generic
drugs.
Read more
as a mechanic in Hyderabad three years ago for what he calls a
more lucrative career: taking part in clinical trials on generic
drugs.
Read more
BRIEF-Regeneus Ltd seeks trading halt
* Seeks trading halt to enable co to complete signing of
transaction documents regarding entry into strategic
collaboration and licensing agreement for Progenza Stem Cell
Technology in Japan
Source text for Eikon:
Further company coverage:
Read more
transaction documents regarding entry into strategic
collaboration and licensing agreement for Progenza Stem Cell
Technology in Japan
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Seattle Genetics says entered tenth amendment to development and supply agreement with Abbvie Inc
* Seattle Genetics - amendment extends term of supply
agreement from August 22, 2021 through and including December
31, 2025
Read more
agreement from August 22, 2021 through and including December
31, 2025
Read more
BRIEF-Neogenomics Inc, some units and Neogenomics Laboratories enter credit agreement - SEC filing
* Neogenomics Inc - on December 22, 2016, Neogenomics
Laboratories Inc and co and units entered into a credit
agreement - SEC filing
Read more
Laboratories Inc and co and units entered into a credit
agreement - SEC filing
Read more
BRIEF-Neogen says acquired Brazil-based Rogama Industria e Comercio Ltda
* Neogen - on December 27, 2016, Neogen Corporation annouced
that it has acquired Brazil-based Rogama Industria e Comercio
Ltda
Read more
that it has acquired Brazil-based Rogama Industria e Comercio
Ltda
Read more
BRIEF-Capnia to pay Essentialis $750,000 if merger is terminated - SEC filing
* Capnia - under merger agreement co to pay Essentialis
termination fee of $750,000 under specified circumstances - SEC
filing
Read more
termination fee of $750,000 under specified circumstances - SEC
filing
Read more
Abbott gets U.S. antitrust approval to buy St. Jude Medical
WASHINGTON, Dec 27 (Reuters) - Healthcare company Abbott
Laboratories has won U.S. antitrust approval for its
proposed purchase of medical device maker St. Jude Medical Inc
, the Federal Trade Commission said on Tuesday.
Read more
Laboratories has won U.S. antitrust approval for its
proposed purchase of medical device maker St. Jude Medical Inc
, the Federal Trade Commission said on Tuesday.
Read more
UPDATE 1-Abbott gets U.S. antitrust approval to buy St. Jude Medical
WASHINGTON, Dec 27 (Reuters) - Healthcare company Abbott
Laboratories has won U.S. antitrust approval for its
proposed purchase of medical device maker St. Jude Medical Inc
, the U.S. Federal Trade Commission said on Tuesday.
Read more
Laboratories has won U.S. antitrust approval for its
proposed purchase of medical device maker St. Jude Medical Inc
, the U.S. Federal Trade Commission said on Tuesday.
Read more
U.S. posts rules for addressing cyber bugs in medical devices
Dec 27 (Reuters) - The U.S. government on Tuesday issued
rules for addressing cyber vulnerabilities in medical devices,
providing manufacturers with guidelines for fixing security bugs
in equipment, including pacemakers, insulin pumps and imaging
systems.
Read more
rules for addressing cyber vulnerabilities in medical devices,
providing manufacturers with guidelines for fixing security bugs
in equipment, including pacemakers, insulin pumps and imaging
systems.
Read more
Fitch: Hypermarcas' Asset Sale is Credit Positive
(The following statement was released by the rating agency)
SAO PAULO, December 27 (Fitch) Hypermarcas' sale of its
Disposable Products
Business to Ontex Group NV (Ontex) is considered credit positive
by Fitch
Ratings, as it strengthens the company's already deleveraged
capital structure.
Depending on the use of proceeds, this transaction could
strengthen Hypermarcas'
ability to generate more robust cash flows from operations
(CFFO) and free cash
flows (FCF), which continue to be key credit
Read more
SAO PAULO, December 27 (Fitch) Hypermarcas' sale of its
Disposable Products
Business to Ontex Group NV (Ontex) is considered credit positive
by Fitch
Ratings, as it strengthens the company's already deleveraged
capital structure.
Depending on the use of proceeds, this transaction could
strengthen Hypermarcas'
ability to generate more robust cash flows from operations
(CFFO) and free cash
flows (FCF), which continue to be key credit
Read more
Sanofi sues Novo Nordisk over diabetes drugs in the U.S.
PARIS/NEW YORK, Dec 27 (Reuters) - France's Sanofi
has filed a lawsuit in the United States accusing Novo Nordisk
of falsely claiming that Sanofi insulin drugs would
no longer be available for many U.S. patients so it could
promote its competing drug.
Read more
has filed a lawsuit in the United States accusing Novo Nordisk
of falsely claiming that Sanofi insulin drugs would
no longer be available for many U.S. patients so it could
promote its competing drug.
Read more
BRIEF-Perceptive Advisors buys 85,275 shares of Amicus Therapeutics on Dec 23
* Perceptive Advisors LLC reports purchase of 85,275 shares
of Amicus Therapeutics Inc's common stock on Dec 23 -
SEC filing
Read more
of Amicus Therapeutics Inc's common stock on Dec 23 -
SEC filing
Read more
US STOCKS-Dow nears 20,000, Nasdaq hits record as tech stocks rise
* Indexes up: Dow 0.17 pct, S&P 0.34 pct, Nasdaq 0.71 pct
(Adds details, comments, updates prices)
Read more
(Adds details, comments, updates prices)
Read more
BRIEF-Pernix Therapeutics ceases discussions on possible restructuring of capital structure
* On Dec 26, 2016, co ceased discussions with noteholders on
possible consensual restructuring of co's capital structure
Read more
possible consensual restructuring of co's capital structure
Read more
UPDATE 1-Seattle Genetics' cancer drug put on clinical hold after 4 deaths
Dec 27 (Reuters) - Seattle Genetics Inc said four
people had died in trials testing its experimental cancer drug,
prompting the U.S. Food and Drug Administration to impose a
clinical hold on several early-stage studies.
Read more
people had died in trials testing its experimental cancer drug,
prompting the U.S. Food and Drug Administration to impose a
clinical hold on several early-stage studies.
Read more
BRIEF-Mimedx announces preliminary investigation findings
* Mimedx Group Inc- company does not anticipate any material
effect on company's financial statements resulting from
investigation findings
Read more
effect on company's financial statements resulting from
investigation findings
Read more
BRIEF-Intelgenx announces agreement with endo ventures
* Intelgenx announces development and commercialization
agreement with endo ventures
Source text for Eikon:
Further company coverage:
Read more
agreement with endo ventures
Source text for Eikon:
Further company coverage:
Read more
Hong Kong's first bird flu patient this winter dies
HONG KONG, Dec 27 (Reuters) - An elderly Hong Kong man died
on Christmas Day from bird flu, the government said on Tuesday,
the first human infection in the city this winter.
Read more
on Christmas Day from bird flu, the government said on Tuesday,
the first human infection in the city this winter.
Read more
BRIEF-Handa Pharmaceuticals announces IPO of 104.4 mln shares
* Says initial public offering of 104.4 million common
shares with par value of T$10 per share
Read more
shares with par value of T$10 per share
Read more
BRIEF-Alba says over 40 percent of Clinica Baviera shareholding entered sale talks
* Says shareholders that add to over 40 percent of Clinica
Baviera shareholding entered talks for the sale of
shares package
Read more
Baviera shareholding entered talks for the sale of
shares package
Read more
BRIEF-Clinica Baviera says Eduardo Baviera, Julio Baviera are not currently involved in sale talks
* Says Eduardo Baviera and Julio Baviera are not currently
involved in sale talks initiated by Alba and other
shareholders
Read more
involved in sale talks initiated by Alba and other
shareholders
Read more
BRIEF-Universal Vision Biotechnology signs memorandum to use 45 mln yuan to set up JV
* Says it signed a memorandum with a Hangzhou-based holding
company and a Shanghai-based IT company to use 45 million yuan
to set up a JV
Read more
company and a Shanghai-based IT company to use 45 million yuan
to set up a JV
Read more
BRIEF-Nacimbio, Pharmstandard, Kedrion Biopharma sign memorandum
* Says with Pharmstandard signs memorandum with
Kedrion Biopharma (Italy) aimed at joint implementation of
projects for production of products from blood plasma
Source text: http://bit.ly/2icy9Oc
Read more
Kedrion Biopharma (Italy) aimed at joint implementation of
projects for production of products from blood plasma
Source text: http://bit.ly/2icy9Oc
Read more
BRIEF-Spain's Clinica Baviera share trading suspended - regulator
* Says trading in Spain's Clinica Baviera SA has
been suspended Source text for Eikon: [http://bit.ly/2hJhu1c
]
Further company coverage:
(Reporting by Madrid Newsroom)
Read more
been suspended Source text for Eikon: [http://bit.ly/2hJhu1c
]
Further company coverage:
(Reporting by Madrid Newsroom)
Read more
Monday, December 26, 2016
Indian state orders poultry cull after bird flu outbreak
BHUBANESWAR, India, Dec 27 (Reuters) - An eastern Indian
state ordered the cull of more than 2,500 chickens and other
poultry after four dead crows and three dead poultry tested
positive for the highly pathogenic H5N1 virus, officials said on
Tuesday.
Read more
state ordered the cull of more than 2,500 chickens and other
poultry after four dead crows and three dead poultry tested
positive for the highly pathogenic H5N1 virus, officials said on
Tuesday.
Read more
Swiss stocks - Factors to watch on Dec 26
ZURICH, Dec 27 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent higher at 8,241 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent higher at 8,241 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
FEATURE-Gay rights groups brave abuse, violence to fight HIV in Cameroon
YAOUNDE, Dec 27 (Thomson Reuters Foundation) - Sitting in a
circle with several other young men in a charity's offices in
Cameroon's capital, Fleur listens intently to the speaker talk
about gay sex before slowly raising his hand.
Read more
circle with several other young men in a charity's offices in
Cameroon's capital, Fleur listens intently to the speaker talk
about gay sex before slowly raising his hand.
Read more
PRESS DIGEST- New York Times business news - Dec 27
Dec 27 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.
Read more
BRIEF-Corestem receives patent
* Says it receives patent about compositions for improving
migration potential of stem cells
Read more
migration potential of stem cells
Read more
BRIEF-Glenmark Pharmaceuticals receives ANDA approval for cancer drug
* Says Glenmark Pharmaceuticals receives ANDA approval for
Tretinoin capsules, 10 mg
Source text: http://bit.ly/2ilDvUs
Further company coverage:
Read more
Tretinoin capsules, 10 mg
Source text: http://bit.ly/2ilDvUs
Further company coverage:
Read more
BRIEF-Zhejiang Yongtai Technology cuts 4.5 pct stake in Jiangxi Fushine Pharmaceutical
* Says the co cut 4.5 percent stake in Jiangxi Fushine
Pharmaceutical Co Ltd, down to 13.3 percent
Read more
Pharmaceutical Co Ltd, down to 13.3 percent
Read more
BRIEF-Jubilant Life Sciences gets members' nod for NCD issue
* Gets members' nod for NCD issue
Source text: http://bit.ly/2ijs4gm
Further company coverage:
Read more
Source text: http://bit.ly/2ijs4gm
Further company coverage:
Read more
Sunday, December 25, 2016
UPDATE 1-China's Suzhou city to halt live poultry trade over bird flu concerns
BEIJING, Dec 25 (Reuters) - A Chinese city said on Sunday it
will suspend the trade of live poultry in the interests of
public health after neighbouring provinces reported cases of
human bird flu infections.
Read more
will suspend the trade of live poultry in the interests of
public health after neighbouring provinces reported cases of
human bird flu infections.
Read more
REFILE-China's Suzhou city to halt live poultry trade on bird flu concerns
BEIJING, Dec 25 (Reuters) - A Chinese city said on Sunday it
will suspend trade of live poultry in the interests of public
health after neighbouring provinces reported cases of human bird
flu infections.
Read more
will suspend trade of live poultry in the interests of public
health after neighbouring provinces reported cases of human bird
flu infections.
Read more
Saturday, December 24, 2016
UPDATE 1-Status Quo guitarist Rick Parfitt dies aged 68
LONDON, Dec 24 (Reuters) - Rick Parfitt, the guitarist of
British rock group Status Quo, died in hospital on Saturday in
Spain aged 68 after suffering from a severe infection.
Read more
British rock group Status Quo, died in hospital on Saturday in
Spain aged 68 after suffering from a severe infection.
Read more
Status Quo guitarist Rick Parfitt dies aged 68
LONDON, Dec 24 (Reuters) - Status Quo guitarist Rick Parfitt
died in hospital on Saturday in Spain aged 68 after suffering
from a severe infection, his manager said.
Read more
died in hospital on Saturday in Spain aged 68 after suffering
from a severe infection, his manager said.
Read more
China uncovers 500,000 food safety violations in nine months
SHANGHAI, Dec 24 (Reuters) - China, rocked in recent years
by a series of food safety scandals, uncovered as many as half a
million illegal food safety violations in the first three
quarters of the year, an official said.
Read more
by a series of food safety scandals, uncovered as many as half a
million illegal food safety violations in the first three
quarters of the year, an official said.
Read more
Friday, December 23, 2016
BRIEF-Mylan unit enters into amendment and waiver agreement to loan agreement dated as of September 17, 2014
* On dec 22, unit of Co entered into amendment and waiver
agreement to loan agreement dated as of September 17, 2014 - SEC
filing
Read more
agreement to loan agreement dated as of September 17, 2014 - SEC
filing
Read more
BRIEF-Celsion files for offering of up to $15 mln in shares of common stock and base warrants
* Files for offering of up to $15 million in shares of
common stock and base warrants - SEC filing
Read more
common stock and base warrants - SEC filing
Read more
BRIEF-Lion Biotech files for mixed shelf of up to $100 mln
* Lion Biotechnologies Inc - files for mixed shelf of up to
$100 million - SEC filing
Source text: (http://bit.ly/2hRk48l)
Further company coverage:
Read more
$100 million - SEC filing
Source text: (http://bit.ly/2hRk48l)
Further company coverage:
Read more
BRIEF-Aina Le'a Inc- no termination fees regarding termination of merger agreement with Origo Acquisition Corporation
* Aina Le'a Inc- there are no termination fees in connection
with termination of merger agreement with Origo Acquisition
Corporation
Source text: (http://bit.ly/2hRj3x2)
Further company coverage:
Read more
with termination of merger agreement with Origo Acquisition
Corporation
Source text: (http://bit.ly/2hRj3x2)
Further company coverage:
Read more
FDA approves Biogen drug for lead genetic cause of infant death
Dec 23 (Reuters) - The U.S. Food and Drug Administration on
Friday said it has approved Biogen Inc's drug to treat
spinal muscular atrophy, the leading genetic cause of death in
infants.
Read more
Friday said it has approved Biogen Inc's drug to treat
spinal muscular atrophy, the leading genetic cause of death in
infants.
Read more
Migraine drugs may repeat rheumatoid arthritis success
Dec 23 (Reuters) - Nearly two decades ago, several drugs to
treat rheumatoid arthritis hit the shelves in rapid succession,
opening up a huge market for the treatment of the autoimmune
joint disorder.
Read more
treat rheumatoid arthritis hit the shelves in rapid succession,
opening up a huge market for the treatment of the autoimmune
joint disorder.
Read more
BRIEF-Portola Pharmaceuticals says FDA accepts NDA for priority review for betrixaban
* Portola Pharmaceuticals announces FDA accepts New Drug
Application for priority review and EMA validates marketing
authorization application for oral, Factor Xa inhibitor
anticoagulant betrixaban
Read more
Application for priority review and EMA validates marketing
authorization application for oral, Factor Xa inhibitor
anticoagulant betrixaban
Read more
BRIEF-Neovasc announces update in litigation with Cardiaq
* Will deposit US$70 million into a joint escrow account and
enter into a general security agreement related to remaining
damages awarded by court
Read more
enter into a general security agreement related to remaining
damages awarded by court
Read more
BRIEF-Align Technology enters agreement to buy four parcels of real estate
* On Dec. 19 co,LBA RIV-COMPANY entered into a purchase and
sale agreement for purchase by company of four parcels of real
estate
Read more
sale agreement for purchase by company of four parcels of real
estate
Read more
UPDATE 3-Cardinal settles with U.S. over suspicious painkiller shipments
NEW YORK, Dec 23 (Reuters) - Cardinal Health Inc
said on Friday it has agreed to pay $44 million to resolve
claims it failed to alert the U.S. Drug Enforcement
Administration (DEA) to suspiciously large orders of addictive
painkillers.
Read more
said on Friday it has agreed to pay $44 million to resolve
claims it failed to alert the U.S. Drug Enforcement
Administration (DEA) to suspiciously large orders of addictive
painkillers.
Read more
BRIEF-Oncobiologics issues $8.35 mln senior secured notes, warrants
* Used a portion of proceeds from sale of notes to pay off
its existing senior secured bank loans
Read more
its existing senior secured bank loans
Read more
Deals of the day-Mergers and acquisitions
Dec 23 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1445 GMT on Friday:
Read more
and disposals were reported by 1445 GMT on Friday:
Read more
BRIEF-EnteroMedics announces 1-for-70 reverse stock split
* Declared a 1-for-70 reverse stock split of co's common
stock, will be effective for trading purposes upon commencement
of trading on Dec 28
Read more
stock, will be effective for trading purposes upon commencement
of trading on Dec 28
Read more
BRIEF-Helix Biopharma successfully out-licenses late stage Biphasix technology
* Under terms of agreement, Xisle has paid an up-front fee
and agreed to subsequent milestone payments
Read more
and agreed to subsequent milestone payments
Read more
BRIEF-Helius Medical Technologies files for mixed shelf of up to $100 mln - SEC filing
* May use a portion of net proceeds to invest,acquire
businesses,technologies we believe are complementary
Source text: (http://bit.ly/2i1SNQX)
Further company coverage:
Read more
businesses,technologies we believe are complementary
Source text: (http://bit.ly/2i1SNQX)
Further company coverage:
Read more
BRIEF-C R Bard's board amends company's By-Laws to implement proxy access
* On Dec 22 board amended co's by-laws to implement proxy
access-SEC filing
Source text: [http://bit.ly/2h8H2np]
Further company coverage:
Read more
access-SEC filing
Source text: [http://bit.ly/2h8H2np]
Further company coverage:
Read more
BRIEF-B-Soft's general manager to buy more shares, shareholder Youngor to sell shares
* Says its general manager plans to buy shares in the
company worth at least 400 million yuan ($57.57 million) from
Dec 26 to June 25, 2017
Read more
company worth at least 400 million yuan ($57.57 million) from
Dec 26 to June 25, 2017
Read more
BRIEF-DSMB positively assesses Mabion's comparative study of MabionCD20 drug
* Said on Thursday that Data and Safety Monitoring Board
(DSMB) assessed clinical data and safety data obtained from
patients in comparative study of the drug MabionCD20 and the
MabThera reference product (MabThera)
Read more
(DSMB) assessed clinical data and safety data obtained from
patients in comparative study of the drug MabionCD20 and the
MabThera reference product (MabThera)
Read more
BRIEF-Autobio Diagnostics to buy Hong Kong Bio-star's automated bio-analyzer business
* Says it plans to buy Hong Kong Bio-star Technology
Development's automated bio-analyzer business for 169.5 million
yuan ($24.40 million)
Read more
Development's automated bio-analyzer business for 169.5 million
yuan ($24.40 million)
Read more
BRIEF-Shanghai Modern Pharmaceutical to invest 98 mln yuan in pharmaceutical unit
* Says it will invest 98 million yuan in a Wuhan-based
pharmaceutical subsidiary, raising stake in the subsidiary to
96.2 percent from 93.2 percent
Read more
pharmaceutical subsidiary, raising stake in the subsidiary to
96.2 percent from 93.2 percent
Read more
UPDATE 2-China reports first two human fatalities from bird flu this winter
BEIJING, Dec 23 (Reuters) - Two people in China's Anhui
province have died from H7N9 bird flu, the first fatalities in
China among this winter's cases, while Macau reported its first
human H7N9 infection since the former Portuguese colony returned
to China in 1999.
Read more
province have died from H7N9 bird flu, the first fatalities in
China among this winter's cases, while Macau reported its first
human H7N9 infection since the former Portuguese colony returned
to China in 1999.
Read more
BRIEF-Vectura signs deal with Mundipharma on respiratory treatments
* Global development programme with Mundipharma for PMDI
inhaled triple therapy (VR2076) for asthma and COPD
Read more
inhaled triple therapy (VR2076) for asthma and COPD
Read more
BRIEF-Celon Pharma and Polfarmex grant license for product distribution in France
* Celon Pharma and Polfarmex SA grant 5-year registration
dossier and distribution right license on solution for dry
powder inhaler in France
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
dossier and distribution right license on solution for dry
powder inhaler in France
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Thursday, December 22, 2016
German stocks - Factors to watch on December 23
FRANKFURT, Dec 23 (Reuters) - The following are some of the
factors that may move German stocks on Friday:
Read more
factors that may move German stocks on Friday:
Read more
BRIEF-Alkem Labs says US FDA closed inspection at co's Daman unit
* Says closure of US FDA inspection at Alkem's Daman
facility
Source text: http://bit.ly/2hOpaCs
Further company coverage:
Read more
facility
Source text: http://bit.ly/2hOpaCs
Further company coverage:
Read more
China to relax foreign investment rules for aged care - State Council
BEIJING, Dec 23 (Reuters) - China is set to relax
regulations for foreign elderly care firms in an effort to
attract investment, the State Council said in a statement issued
on Friday.
Read more
regulations for foreign elderly care firms in an effort to
attract investment, the State Council said in a statement issued
on Friday.
Read more
Singapore Nov factory output expands at fastest pace in over 2-1/2 years
SINGAPORE, Dec 23 (Reuters) - Singapore's industrial
production in November expanded at its fastest annual pace since
March 2014, buoyed by strong electronics and pharmaceuticals
output, data showed on Friday.
Read more
production in November expanded at its fastest annual pace since
March 2014, buoyed by strong electronics and pharmaceuticals
output, data showed on Friday.
Read more
BRIEF-Alteogen receives patent
* Says it received Japan patent on Dec. 21, for modified
antibody in which motif comprising cysteine residue is bound,
modified antibody-drug conjugate comprising the modified
antibody, and production
Read more
antibody in which motif comprising cysteine residue is bound,
modified antibody-drug conjugate comprising the modified
antibody, and production
Read more
BRIEF-EyeGene receives patent
* Says it received Japan patent on Dec. 21, for vaccine for
inducing an improved immune reaction
Read more
inducing an improved immune reaction
Read more
REFILE- Belgium's Ontex to acquire Hypermarcas personal hygiene business
Dec 22 (Reuters) - Belgium's Ontex Group NV said
it has entered into an agreement to acquire the personal hygiene
business of Brazil's Hypermarcas SA for an enterprise
value of 1 billion reais ($304.28 million).
Read more
it has entered into an agreement to acquire the personal hygiene
business of Brazil's Hypermarcas SA for an enterprise
value of 1 billion reais ($304.28 million).
Read more
Many Brazilian women avoiding pregnancy due to Zika fears - study
LONDON, Dec 23 (Reuters) - Brazil should urgently review its
reproductive health policies, scientists said on Friday, to
support the more than 50 percent of potential mothers who say
they want to avoid pregnancy due to fears about the Zika virus.
Read more
reproductive health policies, scientists said on Friday, to
support the more than 50 percent of potential mothers who say
they want to avoid pregnancy due to fears about the Zika virus.
Read more
Guinea trial shows "historic" success for Ebola vaccine
LONDON, Dec 23 (Reuters) - A vaccine developed by Merck
is the first shown to be highly effective in preventing
human infection with Ebola, according to final results from a
clinical trial.
Read more
is the first shown to be highly effective in preventing
human infection with Ebola, according to final results from a
clinical trial.
Read more
BRIEF-Galena Biopharma and its former ceo reached agreement to proposed settlement to resolve an investigation by SEC
* Galena Biopharma -on December 22, co and its former ceo
reached agreement in principle to proposed settlement that would
resolve an investigation by SEC
Read more
reached agreement in principle to proposed settlement that would
resolve an investigation by SEC
Read more
BRIEF-Alcon receives U.S. FDA approval for acrysof iq restor +3.0d multifocal toric intraocular lens
* Alcon - U.S. commercialization expected to start on a
rolling basis in Q1 of 2017 for acrysof iq restor
Read more
rolling basis in Q1 of 2017 for acrysof iq restor
Read more
BRIEF-BPH energy looks to raise about $1.8 mln via rights placement
* Announces a pro rata non-renounceable rights to raise up
to approximately $1.8 million
Source text for Eikon:
Further company coverage:
Read more
to approximately $1.8 million
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Isentric announces intention to raise about $2 mln
* Company intends to raise up to approximately $2 million
before costs, through issue of up to 33.9 million new shares
Source text for Eikon:
Further company coverage:
Read more
before costs, through issue of up to 33.9 million new shares
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Cytrx Corp says files for mixed shelf offering of up to $200 mln- SEC filing
* Cytrx Corp says files for mixed shelf offering of up to
$200 million - SEC filing
Source text: (http://bit.ly/2hdZRJ7)
Further company coverage:
Read more
$200 million - SEC filing
Source text: (http://bit.ly/2hdZRJ7)
Further company coverage:
Read more
BRIEF-Icad says entered into asset purchase agreement with Invivo Corp- SEC filing
* Icad - On Dec 16, 2016, co entered into an asset purchase
agreement between company and Invivo Corporation - SEC filing
Read more
agreement between company and Invivo Corporation - SEC filing
Read more
BRIEF-Poxel announces departure of its CFO Eric Massou
* New chief financial officer will be announced in Q1 of 2017
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Vifor Pharma & Chemocentryx expands alliance to include CCX140 to treat renal diseases
* Vifor Pharma and Chemocentryx announce expansion of kidney
health alliance to include CCX140 to treat renal diseases
Read more
health alliance to include CCX140 to treat renal diseases
Read more
Teva agrees to pay more than $519 mln to settle bribe allegations - DoJ
WASHINGTON, Dec 22 (Reuters) - Teva Pharmaceutical
Industries agreed to pay more than $519 million to
settle criminal and civil allegations that the company paid
bribes to officials in Mexico, Ukraine and Russia to bolster
sales of its pharmaceutical products, the U.S. Justice
Department said in a press release Thursday.
(Reporting by Joel Schectman; Editing by Chizu Nomiyama)
Read more
Industries agreed to pay more than $519 million to
settle criminal and civil allegations that the company paid
bribes to officials in Mexico, Ukraine and Russia to bolster
sales of its pharmaceutical products, the U.S. Justice
Department said in a press release Thursday.
(Reporting by Joel Schectman; Editing by Chizu Nomiyama)
Read more
BRIEF-BrainCool takes up loan of SEK 10 mln
* Takes up loan of 10 million Swedish crowns ($1.09 million)
for preparations for launch in US and financing of acquisition
of BeneChill
Read more
for preparations for launch in US and financing of acquisition
of BeneChill
Read more
Teva to pay US government $519 mln over foreign bribery charges
Dec 22 (Reuters) - Israel's Teva Pharmaceutical Industries
Ltd , said on Thursday it had agreed to pay
$519 million to resolve charges related to the U.S. Foreign
Corrupt Practices Act.
Read more
Ltd , said on Thursday it had agreed to pay
$519 million to resolve charges related to the U.S. Foreign
Corrupt Practices Act.
Read more
BRIEF-Xintela reports positive results from completed horse study
* Says completed horse study met its primary endpoint,
demonstrating that Xintela's stem cells are safe
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
demonstrating that Xintela's stem cells are safe
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Bioanalytical Systems Q4 loss per share $0.25
* Bioanalytical Systems - management to seek alternatives to
enable co to repay indebtedness to Huntington bank in full upon
expiration of forbearance period
Read more
enable co to repay indebtedness to Huntington bank in full upon
expiration of forbearance period
Read more
BRIEF-PerkinElmer says Varian required to pay fee of up to $22.08 mln if deal is terminated
* PerkinElmer - Under circumstances, upon termination of
deal with varian,purchaser will be required to pay company a
termination fee of up to $22.08 million
Source text: (http://bit.ly/2hYKrtq)
Further company coverage:
Read more
deal with varian,purchaser will be required to pay company a
termination fee of up to $22.08 million
Source text: (http://bit.ly/2hYKrtq)
Further company coverage:
Read more
BRIEF-Aurinia announces $25 million bought deal financing
* Aurinia Pharmaceuticals Inc - Underwriters have agreed to
purchase 11.1 million units from company at price of us$2.25 per
unit
Read more
purchase 11.1 million units from company at price of us$2.25 per
unit
Read more
BRIEF-Xoma Corp says entered into two royalty interest acquisition agreements with Healthcare Royalty Partners II
* Xoma corp - under first acquisition agreement,co, unit
sold rights for license dated aug 18,2005 for a payment of $6.5
million upfront
Read more
sold rights for license dated aug 18,2005 for a payment of $6.5
million upfront
Read more
BRIEF-MedFirst Healthcare Services to issue 1st series unsecured convertible corporate bonds of T$300 mln
* Says it will issue the 1st series unsecured convertible
corporate bonds, worth T$300 million
Read more
corporate bonds, worth T$300 million
Read more
BRIEF-Mercator Medical unit signs deal for gloves factory development
* Said on Wednesday that its Thailand-based unit Mercator
Medical (Thailand) Ltd. signed a deal with Thailand-based JWS
Construction Co. Ltd. for development of gloves factory
Read more
Medical (Thailand) Ltd. signed a deal with Thailand-based JWS
Construction Co. Ltd. for development of gloves factory
Read more
Wednesday, December 21, 2016
Actelion battle heats up, Monte Paschi in focus. For more see the European equities LiveMarkets blog
LONDON, Dec 22 (Reuters) - Live coverage of European markets now available
on cpurl://apps.cp./cms/?pageId=livemarkets
Read more
on cpurl://apps.cp./cms/?pageId=livemarkets
Read more
French and Benelux stocks-Factors to watch on Dec. 22
PARIS, Dec 22 (Reuters) - Below are company-related news and
stories from French and Benelux media which could have an impact
on the region's markets or individual stocks.
Read more
stories from French and Benelux media which could have an impact
on the region's markets or individual stocks.
Read more
BRIEF-Tsumara & Co to set up unit for management of Tsumara group companies in China
* Says it plans to set up a wholly owned subsidiary with
capital of 300 million yuan in Shanghai
Read more
capital of 300 million yuan in Shanghai
Read more
BRIEF-MedFirst Healthcare Services to issue new shares for operating funds enrichment
* Says it will issue 3 million new shares of its common
stock with par value of T$10 per share for operating funds
enrichment
Read more
stock with par value of T$10 per share for operating funds
enrichment
Read more
BRIEF-Access Bio receives patent
* Says it receives patent about single-pad strip for an
improved lateral flow assay and a test device
Read more
improved lateral flow assay and a test device
Read more
UPDATE 1-Brazil's Hypermarcas to sell diaper unit to Ontex, source says
SAO PAULO, Dec 22 (Reuters) - Hypermarcas SA,
Brazil's most diversified pharmaceutical firm, has agreed to
sell a diaper business to Belgium's Ontex Group NV
for about 1 billion reais ($300 million) in cash, a person with
knowledge of the transaction said on Wednesday.
Read more
Brazil's most diversified pharmaceutical firm, has agreed to
sell a diaper business to Belgium's Ontex Group NV
for about 1 billion reais ($300 million) in cash, a person with
knowledge of the transaction said on Wednesday.
Read more
Shanghai says treating man diagnosed with bird flu
BEIJING, Dec 22 (Reuters) - Shanghai's health authority has
confirmed it is treating a man diagnosed with H7N9 bird flu, the
third case of human infection in China this week.
Read more
confirmed it is treating a man diagnosed with H7N9 bird flu, the
third case of human infection in China this week.
Read more
BRIEF-Benitec biopharma signs new research and collaboration agreement
* New research and collaboration agreement has been signed
with royal holloway university of london
Source text for Eikon:
Further company coverage:
Read more
with royal holloway university of london
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Oxford Immunotec Global files for a mixed shelf of up to $150 mln
* Oxford Immunotec Global Plc - files for a mixed shelf of
up to $150 million - SEC filing
Source text - http://bit.ly/2hWGDZO
Further company coverage:
Read more
up to $150 million - SEC filing
Source text - http://bit.ly/2hWGDZO
Further company coverage:
Read more
Actelion says enters into exclusive discussions with J&J
ZURICH, Dec 21 (Reuters) - Actelion said on
Wednesday it has entered exclusive negotiations with U.S.
healthcare company Johnson & Johnson regarding what the
Swiss biotech company called a "possible strategic transaction".
Read more
Wednesday it has entered exclusive negotiations with U.S.
healthcare company Johnson & Johnson regarding what the
Swiss biotech company called a "possible strategic transaction".
Read more
UPDATE 1-Actelion re-enters talks with J&J in takeover twist
ZURICH, Dec 21 (Reuters) - The takeover battle surrounding
Actelion heated up on Wednesday when the Swiss biotech
company said it had begun exclusive talks with former suitor
Johnson & Johnson about a "strategic transaction".
Read more
Actelion heated up on Wednesday when the Swiss biotech
company said it had begun exclusive talks with former suitor
Johnson & Johnson about a "strategic transaction".
Read more
BRIEF-Walgreens expands availability of naloxone without a prescription to 33 states and Washington D.C.
* Walgreens expands availability of naloxone without a
prescription to 33 states and washington d.c.
Source text for Eikon:
Further company coverage:
Read more
prescription to 33 states and washington d.c.
Source text for Eikon:
Further company coverage:
Read more
BRIEF-East China city reports new human H7N9 case - Xinhua
* A new human H7N9 avian flu case was reported in Xiamen
City, East China's Fujian Province - Xinhua
Read more
City, East China's Fujian Province - Xinhua
Read more
BRIEF-Vigmed wins tenders in France and Sweden
* Vigmed, together with its distribution partners, wins
tenders in France and Sweden
Source text: http://bit.ly/2h1BfA3
Read more
tenders in France and Sweden
Source text: http://bit.ly/2h1BfA3
Read more
BRIEF-Novartis signs licensing deal with Sunovion Pharma
* Novartis - signed licensing deal with Sunovion Pharma for
US commercial rights to its three treatments for chronic
obstructive pulmonary disease
Source text for Eikon:
Further company coverage:
Read more
US commercial rights to its three treatments for chronic
obstructive pulmonary disease
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Natera provides constellation update
* Natera Inc - announced availability of a microdeletions
testing application for new and existing constellation licensees
worldwide
Read more
testing application for new and existing constellation licensees
worldwide
Read more
BRIEF-Lexicon reports positive top-line results in phase 3 study for sotagliflozin in patients with Type 1 diabetes
* Lexicon reports positive top-line results in second
pivotal phase 3 study for sotagliflozin in patients with type 1
diabetes
Read more
pivotal phase 3 study for sotagliflozin in patients with type 1
diabetes
Read more
Artificial leaf copies nature to manufacture medicine
Dec 21 (Reuters) - Dutch scientists have developed an
artificial leaf that can act as a mini-factory for producing
drugs, an advance that could allow medicines to be produced
anywhere there is sunlight.
Read more
artificial leaf that can act as a mini-factory for producing
drugs, an advance that could allow medicines to be produced
anywhere there is sunlight.
Read more
Deals of the day-Mergers and acquisitions
Dec 21 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1100 GMT on Wednesday:
Read more
and disposals were reported by 1100 GMT on Wednesday:
Read more
BRIEF-Sygnis buys C.B.S. Scientific for us $0.9 mln
* Acquires profitable life sciences tools company C.B.S. Scientific for $0.9 million in cash
and shares
Read more
and shares
Read more
Actelion shares gain on report of progress in Sanofi talks
ZURICH, Dec 21 (Reuters) - Swiss biotech group Actelion's
shares rose by more than 3 percent on Wednesday
following a report that talks with Sanofi are making
progress, increasing optimism that the two will strike a deal.
Read more
shares rose by more than 3 percent on Wednesday
following a report that talks with Sanofi are making
progress, increasing optimism that the two will strike a deal.
Read more
BRIEF-NNIT extends agreement with Lundbeck
* Estimated total value of agreement consisting of three contracts will amount in high
double-digit million Danish crown range
Read more
double-digit million Danish crown range
Read more
BRIEF-Hunan Fangsheng Pharma's buyout fund buys stake in health industry firm
* Says its buyout fund buys 51 percent stake in health
industry development firm for 258 million yuan ($37.13 million)
Read more
industry development firm for 258 million yuan ($37.13 million)
Read more
BRIEF-Sumitomo Dainippon Pharma plans merger between units
* Says co's wholly owned unit Boston Biomedical, Inc will
merge with co's another US-based unit Boston Biomedical Pharma,
Inc, on April 1, 2017
Read more
merge with co's another US-based unit Boston Biomedical Pharma,
Inc, on April 1, 2017
Read more
BRIEF-Enzymatica announces the results from the clinical study ENZY-002
* Says ENZY-002 did not meet its primary endpoint of
significantly lowering virus load compared to placebo in this
mild experimental model of common cold
Read more
significantly lowering virus load compared to placebo in this
mild experimental model of common cold
Read more
Tuesday, December 20, 2016
BRIEF-BioInvent enters research collaboration, issues new shares to Pfizer
* Says announces cancer immunotherapy research collaboration
and license agreement with Pfizer and issues new shares to
Pfizer
Read more
and license agreement with Pfizer and issues new shares to
Pfizer
Read more
BRIEF-UMN Pharma announces exercise of options
* Says 150,000 units of its 20th series options were
exercised to 150,000 shares of its common stock on Dec. 21
Read more
exercised to 150,000 shares of its common stock on Dec. 21
Read more
Swiss stocks - Factors to watch on Dec 21
ZURICH, Dec 21 (Reuters) - Here are some of the main factors
that may affect Swiss stocks on Wednesday:
Read more
that may affect Swiss stocks on Wednesday:
Read more
BRIEF-Fuan Pharmaceutical Group sees 2016 net profit to increase by 289 pct to 268.3 pct
* Sees net profit for 2016 to increase by 238.99 percent to
268.26 percent, or to be 220 million yuan to 239 million yuan,
compared to net profit of 2015 (64.9 million yuan)
Read more
268.26 percent, or to be 220 million yuan to 239 million yuan,
compared to net profit of 2015 (64.9 million yuan)
Read more
BRIEF-Dezhan Health raises 1.51 bln yuan in private placement to fund acquisition, projects
* Says it issues new shares via private placement and raises
1.51 billion yuan in total, to fund acquisition and projects
Read more
1.51 billion yuan in total, to fund acquisition and projects
Read more
BRIEF-Fuan Pharmaceutical Group proposes 2016 dividend payment
* Says co's actual controller proposed to pay a cash
dividend of 2 yuan for every 10 shares and use additional
paid-in capital to distribute 20 new shares for every 10 shares,
as the dividend payment plan for 2016
Read more
dividend of 2 yuan for every 10 shares and use additional
paid-in capital to distribute 20 new shares for every 10 shares,
as the dividend payment plan for 2016
Read more
TPG Capital to acquire healthcare software provider Mediware
Dec 20 (Reuters) - Buyout firm TPG Capital LP has
agreed to acquire Mediware Information Systems Inc, a
healthcare technology company, from another private equity firm,
Thoma Bravo LLC.
Read more
agreed to acquire Mediware Information Systems Inc, a
healthcare technology company, from another private equity firm,
Thoma Bravo LLC.
Read more
BRIEF-Ionis Pharma - enters into separate privately negotiated exchange agreements
* Ionis pharma -on Dec 20, entered into separate privately
negotiated exchange agreements with certain holders of 2.75 pct
convertible notes due 2019
Source text for Eikon: [ID:http://bit.ly/2hXwDMR]
Further company coverage:
Read more
negotiated exchange agreements with certain holders of 2.75 pct
convertible notes due 2019
Source text for Eikon: [ID:http://bit.ly/2hXwDMR]
Further company coverage:
Read more
BRIEF-Agilent Technologies to acquire Multiplicom N.V.
* Agilent Technologies Inc - Agilent is acquiring
Multiplicom for approximately EUR68 million in cash
Read more
Multiplicom for approximately EUR68 million in cash
Read more
BRIEF-Centric Health to purchase 6.75 pct convertible notes
* Intends to purchase through facilities of Toronto stock
exchange for cancellation up to $2.75 million principal amount
Read more
exchange for cancellation up to $2.75 million principal amount
Read more
BRIEF-U.S. FDA expands approved use of Dexcom's G5 mobile continuous glucose monitoring system
* The u.s. Fda expands approved use of dexcom's g5 mobile
continuous glucose monitoring system
Read more
continuous glucose monitoring system
Read more
BRIEF-Meridian Bioscience says Magellan Diagnostics signed exclusive distribution agreement with Medcaptain Medical Technology
* Meridian Bioscience Inc- Magellan Diagnostics business
unit has signed an exclusive distribution agreement with
Medcaptain Medical Technology Co., Ltd
Read more
unit has signed an exclusive distribution agreement with
Medcaptain Medical Technology Co., Ltd
Read more
Arizona agrees to drop use of contested sedative in executions
Dec 20 (Reuters) - Arizona has reached an agreement with
lawyers for death row inmates that would prohibit a sedative
that has been used in executions by lethal injection that took
longer than usual or were botched in several states.
Read more
lawyers for death row inmates that would prohibit a sedative
that has been used in executions by lethal injection that took
longer than usual or were botched in several states.
Read more
UPDATE 1-U.S. extends review of Roche MS drug Ocrevus by three months
ZURICH, Dec 20 (Reuters) - The U.S. Food and Drug
Administration (FDA) has extended its review of Roche's
multiple sclerosis (MS) drug Ocrevus by three months to March
28, the Swiss drugmaker said on Tuesday.
Read more
Administration (FDA) has extended its review of Roche's
multiple sclerosis (MS) drug Ocrevus by three months to March
28, the Swiss drugmaker said on Tuesday.
Read more
UPDATE 1-Akebia in marketing deal for anemia drug with Japan's Otsuka
Dec 20 (Reuters) - Akebia Therapeutics Inc said it
signed a co-development and marketing deal worth up to $1
billion for its experimental anemia drug with Japan's Otsuka
Holdings Co Ltd.
Read more
signed a co-development and marketing deal worth up to $1
billion for its experimental anemia drug with Japan's Otsuka
Holdings Co Ltd.
Read more
BRIEF-Pharmstandard to terminate public status, apply for delisting from Moscow Exchange
* Says board decides to terminate public status of the
company and apply for delisting from Moscow Exchange
Read more
company and apply for delisting from Moscow Exchange
Read more
BRIEF-Biofrontera: EMA recommends indication expansion of ameluz for treatment of basal cell carcinoma
* European Medicines Agency recommends indication expansion
of ameluz for treatment of basal cell carcinoma
Read more
of ameluz for treatment of basal cell carcinoma
Read more
SPECIAL REPORT-How dependence on tax breaks corroded Puerto Rico's economy
ARECIBO, Puerto Rico, Dec 20 (Reuters) - Prudo Jimenez was
born on a sugar farm here in 1941, when agriculture ruled Puerto
Rico's economy. He grew up to be a supervisor for drug maker
Syntex in the 1960s, after U.S. manufacturers came in droves,
seeking a tax haven.
Read more
born on a sugar farm here in 1941, when agriculture ruled Puerto
Rico's economy. He grew up to be a supervisor for drug maker
Syntex in the 1960s, after U.S. manufacturers came in droves,
seeking a tax haven.
Read more
Deals of the day-Mergers and acquisitions
Dec 20 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1500 GMT on Tuesday:
Read more
and disposals were reported by 1500 GMT on Tuesday:
Read more
BRIEF-Factor Therapeutics starts phase II trial of a novel topical biologic
* Factor Therapeutics announces commencement of phase II
trial of a novel topical biologic for the treatment of chronic
wounds
Read more
trial of a novel topical biologic for the treatment of chronic
wounds
Read more
BRIEF-Pain Therapeutics to discuss remoxy ER with FDA
* Plans to meet with FDA in person on Monday, February 13,
2017 to discuss regulatory path forward for remoxy ER
Read more
2017 to discuss regulatory path forward for remoxy ER
Read more
BRIEF-Akebia Therapeutics entered into collaboration, license agreement with Otsuka Pharmaceutical on Dec. 18
* Akebia Therapeutics Inc - on December 18, 2016, co
entered into collaboration and license agreement with Otsuka
pharmaceutical co - sec filing
Read more
entered into collaboration and license agreement with Otsuka
pharmaceutical co - sec filing
Read more
BRIEF-Telemedycyna Polska revenue in Nov. up 13.9 percent YoY
* Nov. revenue at 465,800 zlotys ($109,412), up 13.9 percent
versus year ago
Source text for Eikon:
Further company coverage:
($1 = 4.2573 zlotys)
(Gdynia Newsroom)
Read more
versus year ago
Source text for Eikon:
Further company coverage:
($1 = 4.2573 zlotys)
(Gdynia Newsroom)
Read more
Laser therapy with deep-sea drug kills prostate cancer in trial
LONDON, Dec 20 (Reuters) - A non-surgical treatment for
low-risk prostate cancer in which doctors inject a
light-sensitive drug derived from deep-sea bacteria into a
patient's bloodstream was shown in a trial to kill cancer cells
without destroying healthy tissue.
Read more
low-risk prostate cancer in which doctors inject a
light-sensitive drug derived from deep-sea bacteria into a
patient's bloodstream was shown in a trial to kill cancer cells
without destroying healthy tissue.
Read more
BRIEF-Fresenius places 1 bln euros of Schuldschein loans
* Given the substantial investor demand, the volume of the
issuance was significantly upsized
Further company coverage:
Read more
issuance was significantly upsized
Further company coverage:
Read more
UPDATE 1-GSK's two-drug HIV therapy shines in two big studies
* Dolutegravir and rilpivirine work well in Phase III tests
(Adds further reaction, more detail on competition)
Read more
(Adds further reaction, more detail on competition)
Read more
Monday, December 19, 2016
Swiss stocks - Factors to watch on Dec 20
ZURICH, Dec 20 (Reuters) - The Swiss blue-chip SMI
was seen opening 0.1 percent higher at 8,245 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
was seen opening 0.1 percent higher at 8,245 points on Tuesday,
according to premarket indications by bank Julius Baer
.
Read more
BRIEF-Pharnext completes patient enrollment in Pivotal Phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease Type 1a
* Pharnext completes patient enrollment in international
pivotal phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease
Type 1a
Read more
pivotal phase 3 trial of PXT3003 for Charcot-Marie-Tooth Disease
Type 1a
Read more
BRIEF-Medical&Biological Laboratories to set up unit in China
* Says it to set up a wholly owned unit in China named MBL
Hangzhou Biotech Co., Ltd in Feb. 2017
Read more
Hangzhou Biotech Co., Ltd in Feb. 2017
Read more
BRIEF-UCB and Amgen seek marketing approval of romosozumab in Japan
* Says Amgen and UCB announce submission of
application for investigational osteoporosis medication
romosozumab in Japan
Read more
application for investigational osteoporosis medication
romosozumab in Japan
Read more
UPDATE 1-Japan to review drug prices more frequently to curb rising healthcare costs
TOKYO, Dec 20 (Reuters) - Japan said on Tuesday it planned
to start reviewing prescription drug prices once a year,
increasing their frequency from once every two years, as the
government tries to curb mounting healthcare costs in a rapidly
ageing society.
Read more
to start reviewing prescription drug prices once a year,
increasing their frequency from once every two years, as the
government tries to curb mounting healthcare costs in a rapidly
ageing society.
Read more
Hong Kong confirms first case of bird flu this season
HONG KONG, Dec 20 (Reuters) - Hong Kong authorities have
confirmed the first human bird flu infection for this season
after an elderly man who had recently travelled to mainland
China was diagnosed with the deadly H7N9 virus strain.
Read more
confirmed the first human bird flu infection for this season
after an elderly man who had recently travelled to mainland
China was diagnosed with the deadly H7N9 virus strain.
Read more
BRIEF-Sun Pharmaceutical Industries announces voluntary withdrawal of 28 ANDAs
* Says older drug products belong to erstwhile ranbaxy
laboratories ltd. And are not being marketed in us since 2008
Read more
laboratories ltd. And are not being marketed in us since 2008
Read more
BRIEF-Viiv Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen
* Viiv Healthcare announces positive results from first
phase iii studies of two-drug HIV treatment regimen
Read more
phase iii studies of two-drug HIV treatment regimen
Read more
BRIEF-Theravance biopharma highlights initiation of Phase 3 study
* Theravance Biopharma highlights initiation of phase 3
study of the closed triple in patients with asthma by
glaxosmithkline and innoviva
Read more
study of the closed triple in patients with asthma by
glaxosmithkline and innoviva
Read more
BRIEF-Janssen Sciences Ireland UC says positive results from first Phase III studies of investigational two-drug HIV treatment regimen
* Press release - Positive results from first Phase III
studies of investigational two-drug HIV treatment regimen
Read more
studies of investigational two-drug HIV treatment regimen
Read more
BRIEF-Conatus to receive $50 mln in liver drug deal with Novartis
* Conatus Pharmaceuticals Inc says full funding in position
for remaining development of Emricasan
Read more
for remaining development of Emricasan
Read more
UPDATE 2-Biogen names top executive Vounatsos as CEO
Dec 19 (Reuters) - Biogen Inc, the U.S. drug maker
focused on neurological, autoimmune and rare diseases, said on
Monday it had appointed its chief commercial officer, Michel
Vounatsos, as chief executive officer, ending a five-month
search.
Read more
focused on neurological, autoimmune and rare diseases, said on
Monday it had appointed its chief commercial officer, Michel
Vounatsos, as chief executive officer, ending a five-month
search.
Read more
BRIEF-Foundation Medicine receives FDA approval of Foundationfocus
* Foundation Medicine receives FDA approval of
Foundationfocus CDXBRCA as a companion diagnostic for
Rubraca(Rucaparib) for the treatment of women with ovarian
cancer
Source text for Eikon:
Further company coverage:
Read more
Foundationfocus CDXBRCA as a companion diagnostic for
Rubraca(Rucaparib) for the treatment of women with ovarian
cancer
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Imprimis Pharmaceuticals announces $9.8 mln private placement of units
* Has agreed to sell an aggregate of approximately 5.1
million units at a purchase price of $1.915 per unit
Read more
million units at a purchase price of $1.915 per unit
Read more
Deals of the day-Mergers and acquisitions
Dec 19 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Monday:
Read more
and disposals were reported by 2100 GMT on Monday:
Read more
BRIEF-Sucampo announces proposed convertible senior note offering
* Sucampo Pharmaceuticals Inc says intention to offer
$225.0 million principal amount of convertible senior notes due
2021 in a private offering
Read more
$225.0 million principal amount of convertible senior notes due
2021 in a private offering
Read more
BRIEF-Ceterix Orthopaedics Inc says raises about $23 mln in equity financing
* Ceterix Orthopaedics Inc says it has raised about $23
million in equity financing - SEC filing
Read more
million in equity financing - SEC filing
Read more
CORRECTED-UPDATE 1-Ionis Pharma's rare metabolic disorder drug succeeds key study
Dec 19 (Reuters) - Ionis Pharmaceuticals Inc said
on Monday its rare metabolic disorder drug for severe
hypertriglyceridemia, characterized by elevated levels of a type
of fat in the blood, met the main goal in a late-stage study.
Read more
on Monday its rare metabolic disorder drug for severe
hypertriglyceridemia, characterized by elevated levels of a type
of fat in the blood, met the main goal in a late-stage study.
Read more
BRIEF-Anika wins CE mark approval for Orthovisc-T
* Anika wins CE mark approval for Orthovisc-T to relieve
pain and restore function of tendons damaged by chronic injury
Read more
pain and restore function of tendons damaged by chronic injury
Read more
Ducks culled in Bulgaria after bird flu found on three farms
SOFIA, Dec 19 (Reuters) - More than 4,000 ducks were culled
in Bulgaria over the past few days after bird flu was found on
three farms, the Bulgarian food safety agency said on Monday.
Read more
in Bulgaria over the past few days after bird flu was found on
three farms, the Bulgarian food safety agency said on Monday.
Read more
UPDATE 1-Clovis's ovarian cancer drug wins accelerated FDA approval
Dec 19 (Reuters) - The U.S. Food and Drug Administration
said on Monday it granted accelerated approval to Clovis
Oncology Inc's ovarian cancer drug in patients whose
disease advanced despite chemotherapy.
Read more
said on Monday it granted accelerated approval to Clovis
Oncology Inc's ovarian cancer drug in patients whose
disease advanced despite chemotherapy.
Read more
UPDATE 1-Japan to review drug prices annually rather than every two years -sources
TOKYO, Dec 19 (Reuters) - The Japanese government plans to
start reviewing drug prices every year, instead of every two
years, to try to reduce mounting healthcare costs, government
officials with direct knowledge of the decision said on Monday.
Read more
start reviewing drug prices every year, instead of every two
years, to try to reduce mounting healthcare costs, government
officials with direct knowledge of the decision said on Monday.
Read more
BRIEF-Kindred Healthcare, Atlantic Health System plans for inpatient rehabilitation hospital
* Kindred Healthcare Inc says joint venture will construct
and operate a 38-bed hospital in northern New Jersey
Read more
and operate a 38-bed hospital in northern New Jersey
Read more
BRIEF-Endologix wins Australia approval for abdominal aortic aneurysm device
* Endologix receives australian therapeutic goods
administration (TGA) approval for AFX2 bifurcated endograft
system
Source text for Eikon:
Further company coverage:
Read more
administration (TGA) approval for AFX2 bifurcated endograft
system
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Adaptimmune, Bellicum Pharma collaborate to evaluate next-generation T-cell therapies
* Adaptimmune and Bellicum Pharmaceuticals enter a strategic
collaboration to evaluate next-generation T-cell therapies
Read more
collaboration to evaluate next-generation T-cell therapies
Read more
BRIEF-EDAP TMS announces publication of results comparing Ablatherm focal HIFU with robotic radical prostatectomy
* EDAP TMS SA - Announced publication of results comparing
ablatherm focal HIFU with robotic radical prostatectomy
Read more
ablatherm focal HIFU with robotic radical prostatectomy
Read more
BRIEF-Prometic to submit biologics license application for plasminogen with U.S. FDA
* Prometic initiates rolling submission of its biologics
license application ("BLA") for plasminogen with U.S. FDA
Read more
license application ("BLA") for plasminogen with U.S. FDA
Read more
BRIEF-Lotus Pharmaceutical says Lin Tong-Ho retired from chairman
Dec 19 (Reuters) - Lotus Pharmaceutical :
* Says Lin Tong-Ho retired from chairman of the board
Source text in Chinese: https://goo.gl/gcc1xW
Further company coverage:
(Beijing Headline News)
Read more
BRIEF-Versant Ventures announces milestone with Northern Biologics and Bluerock Therapeutics
* Versant ventures announces milestone with recent Northern
Biologics and Bluerock Therapeutics deals
Read more
Biologics and Bluerock Therapeutics deals
Read more
Japan to review drug prices annually vs every two years previously -sources
TOKYO, Dec 19 (Reuters) - The Japanese government plans to
start reviewing drug prices every year, instead of every two
years, in a bid to reduce mounting healthcare costs, government
officials with direct knowledge of the decision said on Monday.
Read more
start reviewing drug prices every year, instead of every two
years, in a bid to reduce mounting healthcare costs, government
officials with direct knowledge of the decision said on Monday.
Read more
Israel's BrainStorm to begin advanced trial for ALS stem cell treatment
TEL AVIV, Dec 19 (Reuters) - Israel's BrainStorm Cell
Therapeutics said it is proceeding to a Phase 3
clinical trial for its adult stem cell treatment in patients
with amyotrophic lateral sclerosis (ALS).
Read more
Therapeutics said it is proceeding to a Phase 3
clinical trial for its adult stem cell treatment in patients
with amyotrophic lateral sclerosis (ALS).
Read more
REFILE-UPDATE 1-Poultry culled in Germany after bird flu found on two farms
HAMBURG, Germany, Dec 19 (Reuters) - About 30,000 turkeys
and ducks were culled in Germany over the weekend after bird flu
was found on two farms, authorities said on Monday.
Read more
and ducks were culled in Germany over the weekend after bird flu
was found on two farms, authorities said on Monday.
Read more
UPDATE 1-SCA to buy wound care firm BSN medical for 2.7 bln euros
STOCKHOLM, Dec 19 (Reuters) - Sweden's SCA said on
Monday it was buying German bandage and plaster cast maker BSN
medical for 2.74 billion euros ($2.9 bln) from private equity
firm EQT in a deal expected to boost the Swedish firm's growth.
Read more
Monday it was buying German bandage and plaster cast maker BSN
medical for 2.74 billion euros ($2.9 bln) from private equity
firm EQT in a deal expected to boost the Swedish firm's growth.
Read more
Sunday, December 18, 2016
BRIEF-Grifols approves succession plan for CEO
* Appoints Raimon Grifols Roura and Victor Grifols Deu as
chief executive officers effective Jan. 1
Read more
chief executive officers effective Jan. 1
Read more
BRIEF-Scandidos gets order on Delta4 Phantom+ to Greece
* Deliveries of therapy systems will be done separately for each hospital during period of
18 months while Delta4Phantom+ system will be delivered during Scandidos Q4
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
18 months while Delta4Phantom+ system will be delivered during Scandidos Q4
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Swiss stocks - Factors to watch on Dec 19
ZURICH, Dec 19 (Reuters) - Here are some of the main factors
that may affect Swiss stocks on Monday:
Read more
that may affect Swiss stocks on Monday:
Read more
BRIEF-Shionogi & Co Ltd signs strategic business alliance for sale of peripheral mu opioid receptor antagonist Symproic in U.S with Purdue Pharma L.P
* Says it signed a strategic business alliance for sale of
peripheral mu opioid receptor antagonist Symproic in U.S with
Purdue Pharma L.P
Read more
peripheral mu opioid receptor antagonist Symproic in U.S with
Purdue Pharma L.P
Read more
BRIEF-Dorsavi signs a 12-month contract to deliver visafe services
* Signed a 12-month contract which will see dorsavi deliver
a range of visafe services in three phases
Read more
a range of visafe services in three phases
Read more
PRESS DIGEST- Financial Times - Dec 19
Dec 19 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
BRIEF-A Soriano Corp signs deal to sell property for 397.1 mln pesos
* Signed a deed of absolute sale dated dec 16 for sale of
its Cebu Business Park Lot to Skyrise Realty And Development
Corporation
Read more
its Cebu Business Park Lot to Skyrise Realty And Development
Corporation
Read more
BRIEF-Simavita says received $1.7 mln R&D tax incentive
* Confirms receipt of $1.7 million under Australian
Government's research and development tax incentive scheme
Source text for Eikon:
Further company coverage:
Read more
Government's research and development tax incentive scheme
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Universal Biosensors' unit acquires hemostasis reference laboratory business
* Canada unit signed an agreement with Lifelabs LP to
acquire assets of Lifelabs' hemostasis reference laboratory
business
Read more
acquire assets of Lifelabs' hemostasis reference laboratory
business
Read more
BRIEF-SCA nearing deal to buy BSN Medical for 2.7 bln euros- FT,citing sources
* Sweden's SCA is nearing a deal to buy bsn medical for 2.7
billion euros including debt- FT,citing sources
Read more
billion euros including debt- FT,citing sources
Read more
Saudi Aramco, GE to launch Saudi Arabia's first wind turbine next month
KHOBAR, Saudi Arabia, Dec 18 (Reuters) - Saudi Aramco plans
to commission its wind turbine pilot project, the first in the
kingdom, next month, the state oil company said on Sunday, part
of nationwide plans to diversify energy supplies and to meet an
increase in demand.
Read more
to commission its wind turbine pilot project, the first in the
kingdom, next month, the state oil company said on Sunday, part
of nationwide plans to diversify energy supplies and to meet an
increase in demand.
Read more
BRIEF-Yonker Environmental Protection to set up health insurance JV
* Says it to set up a health insurance JV with a Tibet-based
investment firm, Hunan TV & Broadcast Intermediary Co Ltd
, Talkweb Information System Co Ltd,
Centre Testing International Group Co Ltd, and
Chongqing Lummy Pharmaceutical Co Ltd
Read more
investment firm, Hunan TV & Broadcast Intermediary Co Ltd
, Talkweb Information System Co Ltd,
Centre Testing International Group Co Ltd, and
Chongqing Lummy Pharmaceutical Co Ltd
Read more
Saturday, December 17, 2016
BRIEF-Zhejiang Hisun Pharmaceutical appoints Guan Xuhua as CFO
Dec 17 (Reuters) - Zhejiang Hisun Pharmaceutical Co Ltd
:
* Says it appoints Guan Xuhua as CFO to replace Hu Liangbin
Source text in Chinese: https://goo.gl/aWixl4
Further company Coverage:
(Beijing Headline News)
Read more
China considers national appeals court on intellectual property rights - paper
BEIJING, Dec 17 (Reuters) - China is considering a national
appeals court specializing in intellectual property rights, the
China Daily has cited a senior Chinese judge as saying, as the
world's second-largest economy tightens regulation of patents
and trademarks.
Read more
appeals court specializing in intellectual property rights, the
China Daily has cited a senior Chinese judge as saying, as the
world's second-largest economy tightens regulation of patents
and trademarks.
Read more
BRIEF-Guangzhou Wondfo Biotech to hold 51 pct stake in biotechnology firm
* Says it to hold 51 percent stake in a Xiamen-based
biotechnology firm after stake acquisition and capital injection
Read more
biotechnology firm after stake acquisition and capital injection
Read more
Friday, December 16, 2016
BRIEF-James Flynn reports 10.9 pct passive stake in Recro Pharma Inc
* James flynn reports 10.9 percent passive stake in recro
pharma inc as of dec. 16, 2016 - sec filing
Source text http://bit.ly/2gUriaR
Further company coverage:
Read more
pharma inc as of dec. 16, 2016 - sec filing
Source text http://bit.ly/2gUriaR
Further company coverage:
Read more
UPDATE 1-U.S. lawmakers press Heritage Pharma on high prices for antibiotic
WASHINGTON, Dec 16 (Reuters) - Two U.S. lawmakers are
questioning whether Heritage Pharmaceuticals misled them in
response to a 2014 congressional inquiry about the rising price
a common antibiotic, after 20 U.S. states this week accused the
company of price fixing.
Read more
questioning whether Heritage Pharmaceuticals misled them in
response to a 2014 congressional inquiry about the rising price
a common antibiotic, after 20 U.S. states this week accused the
company of price fixing.
Read more
Canadian marijuana companies look to get creative with brand building
OTTAWA, Dec 16 (Reuters) - Canadian marijuana firms, facing
potential limits on advertising for recreational pot, are
selling health food products and cultivating a lifestyle image
to win customers in an anticipated multibillion dollar market.
Read more
potential limits on advertising for recreational pot, are
selling health food products and cultivating a lifestyle image
to win customers in an anticipated multibillion dollar market.
Read more
BRIEF-Amarin corp says providing contractual reminder to holders of 3.50% senior notes
* Amarin Corp says providing contractual reminder to holders
of outstanding 3.50% exchangeable senior notes due 2032 of its
wholly owned subsidiary, corsicanto
Read more
of outstanding 3.50% exchangeable senior notes due 2032 of its
wholly owned subsidiary, corsicanto
Read more
BRIEF-Casi Pharmaceuticals Inc entered into amendment with Talon Therapeutics
* Casi Pharmaceuticals Inc - pursuant to first amendment,
company and talon agreed to change maturity date of note to
march 17, 2017 - SEC filing
Read more
company and talon agreed to change maturity date of note to
march 17, 2017 - SEC filing
Read more
FDA drops black box warning on Pfizer's anti-smoking drug
Dec 16 (Reuters) - U.S. health regulators on Friday allowed
Pfizer Inc to remove a serious warning from the label of
its smoking cessation treatment, Chantix, giving a new lease of
life to the controversial drug that was approved a decade ago.
Read more
Pfizer Inc to remove a serious warning from the label of
its smoking cessation treatment, Chantix, giving a new lease of
life to the controversial drug that was approved a decade ago.
Read more
BRIEF-Pfizer says FDA drops black box warning on anti-smoking drug Chantix
* FDA approves removal of boxed warning regarding serious
neuropsychiatric events from Chantix (Varenicline) labeling
Read more
neuropsychiatric events from Chantix (Varenicline) labeling
Read more
Fitch Revises Sanofi's Outlook to Negative; Affirms IDR at 'AA-'
(The following statement was released by the rating agency)
LONDON, December 16 (Fitch) Fitch Ratings has revised French
pharmaceutical
company Sanofi SA's Outlook to Negative from Stable and affirmed
the group's
Long-Term Issuer Default Rating (IDR) at 'AA-'. Fitch has also
affirmed the
senior unsecured rating 'AA-' and Short-term IDR at 'F1+'.
The revision of the Outlook to Negative reflects Fitch's belief
that Sanofi's
financial leverage, cash generation and liquidity will be
affected by
Read more
LONDON, December 16 (Fitch) Fitch Ratings has revised French
pharmaceutical
company Sanofi SA's Outlook to Negative from Stable and affirmed
the group's
Long-Term Issuer Default Rating (IDR) at 'AA-'. Fitch has also
affirmed the
senior unsecured rating 'AA-' and Short-term IDR at 'F1+'.
The revision of the Outlook to Negative reflects Fitch's belief
that Sanofi's
financial leverage, cash generation and liquidity will be
affected by
Read more
BRIEF-Xbiotech says received Day 180 List Of Outstanding Issues from EMA for Xilonix - SEC filing
* Xbiotech-Announced it received Day 180 List Of Outstanding
Issues from European Medicines Agency's Committee for Medicinal
Products for Human Use
Read more
Issues from European Medicines Agency's Committee for Medicinal
Products for Human Use
Read more
BRIEF-MiMedx 2017 guidance forecasts revenue growth in excess of 21%, operating earnings growth in excess of 90%
* MiMedx 2017 guidance forecasts revenue growth in excess of
21% and operating earnings growth in excess of 90%
Read more
21% and operating earnings growth in excess of 90%
Read more
BRIEF-Adocia and Lilly announce successful completion of an insulin pump study with BioChaperone Lispro in people with type 1 diabetes
* Adocia and Lilly announce successful completion of an
insulin pump study with Biochaperone Lispro in people with Type
1 diabetes
Read more
insulin pump study with Biochaperone Lispro in people with Type
1 diabetes
Read more
BRIEF-Pharmacolog: First Swedish hospital signs DrugLog agreement
* Blekinge Hospital in Karlskrona will be the first hospital
in Sweden to sign agreement for the use of DrugLog
Read more
in Sweden to sign agreement for the use of DrugLog
Read more
BRIEF-RLS Global to carry out directed new issue and rights issue totaling SEK 70 mln
* Says has decided to carry out a directed new issue and a
rights issue totaling 70 million Swedish crowns ($7.46 million)
Read more
rights issue totaling 70 million Swedish crowns ($7.46 million)
Read more
BRIEF-Ophthotech determined to implement reduction in personnel to focus on updated business plan
* Ophthotech Corp - determined to stop treating patients who
are in second twelve months of both its phase 3 clinical trials
Read more
are in second twelve months of both its phase 3 clinical trials
Read more
BRIEF-Amgen receives positive response from EMA for its single-dose delivery injection Repatha
* Top-line results from approximately 27,500-patient
event-driven fourier study are anticipated in q1 of 2017
Read more
event-driven fourier study are anticipated in q1 of 2017
Read more
UPDATE 1-Mylan launches EpiPen generic at more than 50 pct discount
Dec 16 (Reuters) - Mylan NV said on Friday it would
start selling a generic version of its life-saving EpiPen
allergy treatment at a more than 50 percent discount, a day
after 20 U.S. states filed a lawsuit against generic drugmakers
including Mylan over prices.
Read more
start selling a generic version of its life-saving EpiPen
allergy treatment at a more than 50 percent discount, a day
after 20 U.S. states filed a lawsuit against generic drugmakers
including Mylan over prices.
Read more
BRIEF-Formonar Investments raises stake in Infoscan to 20.39 pct
* Cyprus-based Formonar Investments Limited raises stake in
the company to 20.39 percent from 7.99 percent through the
acquistion of about 0.3 mln of shares
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
the company to 20.39 percent from 7.99 percent through the
acquistion of about 0.3 mln of shares
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Alnylam Pharmaceuticals announces positive preliminary results from phase 1 study of ALN-TTRsc02
* Alnylam Pharmaceuticals- assuming positive phase 3 data,
co plans to submit NDA,marketing authorisation application
year-end 2017
Read more
co plans to submit NDA,marketing authorisation application
year-end 2017
Read more
Aleppo evacuation halted without explanation - WHO
GENEVA, Dec 16 (Reuters) - The evacuation of wounded and
civilians from eastern enclaves of Aleppo was aborted on Friday,
and aid agencies and vehicles told to leave the area without
explanation, the World Health Organization (WHO) said on Friday.
Read more
civilians from eastern enclaves of Aleppo was aborted on Friday,
and aid agencies and vehicles told to leave the area without
explanation, the World Health Organization (WHO) said on Friday.
Read more
BRIEF-Haisco Pharma to sell 18 pct stake in Haisthera Associates
* Says it plans to sell 18 percent stake in Haisthera
Associates to Haisthera Advisor for $198,700
Read more
Associates to Haisthera Advisor for $198,700
Read more
Thursday, December 15, 2016
BRIEF-Care Service to set up unit in Japan
* Says the unit to be engaged in human resource agency
business, recruitment worker, temporary staffing business
Read more
business, recruitment worker, temporary staffing business
Read more
BRIEF-UK's CMA provisionally finds Actavis UK has broken competition law
* Has provisionally found that Actavis UK has broken
competition law by charging excessive prices to NHS for
hydrocortisone tablets.
Read more
competition law by charging excessive prices to NHS for
hydrocortisone tablets.
Read more
Novartis says buys Ziarco Group to expand skin care portfolio
ZURICH, Dec 16 (Reuters) - Novartis is buying
privately held drugmaker Ziarco Group for an undisclosed sum to
gain access to its investigational eczema medicine, the Swiss
pharmaceutical giant said on Friday.
Read more
privately held drugmaker Ziarco Group for an undisclosed sum to
gain access to its investigational eczema medicine, the Swiss
pharmaceutical giant said on Friday.
Read more
Swiss stocks - Factors to watch on Dec 16
ZURICH, Dec 16 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Friday:
Read more
main factors expected to affect Swiss stocks on Friday:
Read more
BRIEF-Sincere lists on TSE Mothers
Dec 16 (Reuters) - Sincere Co Ltd :
* Says it began listing on TSE Mothers on Dec. 16
Source text in Japanese: https://goo.gl/1Z7zb7
Further company Coverage:
(Beijing Headline News)
Read more
BRIEF-Amicus Therapeutics prices convertible senior notes offering
* notes to bear interest at 3.00% per annum, payable
semi-annually on June 15 & Dec 15 of each year, beginning on
June 15, 2017
Read more
semi-annually on June 15 & Dec 15 of each year, beginning on
June 15, 2017
Read more
Obamacare repeal could take months; replacement, years -Republican aides
WASHINGTON, Dec 15 (Reuters) - Repealing Obamacare could
take months and developing replacement health insurance plans
could take years, senior Republican aides in the U.S. Congress
said on Thursday, discouraging talk of a quick end to the
program after President-elect Donald Trump takes office on Jan.
20.
Read more
take months and developing replacement health insurance plans
could take years, senior Republican aides in the U.S. Congress
said on Thursday, discouraging talk of a quick end to the
program after President-elect Donald Trump takes office on Jan.
20.
Read more
BRIEF-AFT Pharmaceuticals says request for proposal issued by PHARMAC
* RFP seeks proposals for either dual listing or sole supply
of metoprolol in New Zealand with submission due date of 27 jan
2017
Read more
of metoprolol in New Zealand with submission due date of 27 jan
2017
Read more
UPDATE 2-U.S. judge halts Texas rules on fetal tissue disposal
AUSTIN, Texas, Dec 15 (Reuters) - A U.S. judge on Thursday
temporarily halted until Jan. 6 a Texas regulation that would
require abortion providers to dispose of aborted fetal tissue
through burial or cremation, court documents showed.
Read more
temporarily halted until Jan. 6 a Texas regulation that would
require abortion providers to dispose of aborted fetal tissue
through burial or cremation, court documents showed.
Read more
UPDATE 1-U.S.-based stock ETFs rake in cash as Fed raises rates -Lipper
(Adds data on mutual funds and ETFs, context, analyst quote,
table, byline)
By Trevor Hunnicutt
NEW YORK, Dec 15 (Reuters) - Investors piled into stock
exchange-traded funds at the fastest pace since their
record-setting haul following the U.S. presidential election,
Lipper said on Thursday, as policymakers raised interest rates.
U.S.-based equity ETFs took in nearly $18 billion in cash in
the seven days through Wednesday, while U.S.-based stock mutual
funds posted cash withdrawal
Read more
BRIEF-Vericel corporation announces proposed public offering of common stock
* Vericel-Net proceeds to be used primarily to support
commercialization of maci, expand promotional efforts for
epicel, expand, optimize manufacturing
Read more
commercialization of maci, expand promotional efforts for
epicel, expand, optimize manufacturing
Read more
Rotation from U.S.-based bond funds to stocks accelerates -Lipper
NEW YORK, Dec 15 (Reuters) - Investors poured $6.8 billion
into U.S.-based stock funds in the week through Dec. 14, Lipper
data showed on Thursday, accelerating a rotation from bonds to
stocks as U.S. policymakers raised interest rates for the first
time in a year.
Read more
into U.S.-based stock funds in the week through Dec. 14, Lipper
data showed on Thursday, accelerating a rotation from bonds to
stocks as U.S. policymakers raised interest rates for the first
time in a year.
Read more
BRIEF-Milestone Scientific reports proposed public offering of common stock and warrants
* Milestone Scientific Inc announces proposed public
offering of common stock and warrants
Source text for Eikon:
Further company coverage:
Read more
offering of common stock and warrants
Source text for Eikon:
Further company coverage:
Read more
Chemical companies pitch bug-killing options amid neonic farm bans
WINNIPEG, Manitoba, Dec 15 (Reuters) - Companies that make
bug-killing chemicals and natural remedies are racing to take
advantage of restrictions on neonics, a type of insecticide
popular with farmers but blamed for harming bees and mayflies.
Read more
bug-killing chemicals and natural remedies are racing to take
advantage of restrictions on neonics, a type of insecticide
popular with farmers but blamed for harming bees and mayflies.
Read more
BRIEF-Allergan announces civil resolution concluding federal investigation into Forest sales & marketing practices
* Allergan announces civil resolution concluding federal
investigation into Forest sales & marketing practices
Read more
investigation into Forest sales & marketing practices
Read more
UPDATE 2-U.S. states sue Mylan, Teva, others for fixing drug prices
WASHINGTON, Dec 15 (Reuters) - Two years after high generic
drug prices became a public controversy, legal cases are
starting to land.
Read more
drug prices became a public controversy, legal cases are
starting to land.
Read more
BRIEF-Aptevo Therapeutics amends collaboration agreement with Morphosys AG for Novel Immunotherapeutic
* Under terms of third amendment, Aptevo Research and
Development will bear 75 pct of all development costs with
respect to MOR209/es414
Read more
Development will bear 75 pct of all development costs with
respect to MOR209/es414
Read more
UPDATE 1-Britain agrees to license three-parent IVF babies to prevent disease
LONDON, Dec 15 (Reuters) - Britain on Thursday became the
first country to formally license an in-vitro fertilisation
(IVF) treatment designed to create babies from three people.
Read more
first country to formally license an in-vitro fertilisation
(IVF) treatment designed to create babies from three people.
Read more
Aid trucks with medical supplies leave Paris for northern Syria
PARIS, Dec 15 (Reuters) - Two trucks filled with 20 tonnes
of first aid supplies and construction materials left Paris for
northern Syria on Thursday to help those fleeing conflict in
Aleppo.
Read more
of first aid supplies and construction materials left Paris for
northern Syria on Thursday to help those fleeing conflict in
Aleppo.
Read more
BRIEF-Abivax appoints Didier Blondel as Chief Financial Officer
* Chief Financial Officer appointment effective January 2(nd), 2017
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Ahead Global Investment publishes final results of mandatory offer on MediRox, delisting of company initiated
* Ahead Global Investment Ltd publishes final results of mandatory offer on MediRox AB
(publ), delisting of company initiated
Read more
(publ), delisting of company initiated
Read more
Fitch Rates UnitedHealth Group's Planned Issuance 'A-(EXP)'
(The following statement was released by the rating agency)
CHICAGO, December 15 (Fitch) Fitch Ratings has assigned an
'A-(EXP)' rating to
UnitedHealth Group Incorporated's (UNH) planned benchmark
offering of senior
unsecured notes in a mix of 10 and 30 year maturities. Fitch
expects the
issuance to be between $1.0 billion and $1.5 billion. The
ratings are equivalent
to Fitch's ratings on UNH's outstanding senior unsecured notes.
UNH's 'A' Issuer
Default Rating (IDR) Outlook is currently Ne
Read more
CHICAGO, December 15 (Fitch) Fitch Ratings has assigned an
'A-(EXP)' rating to
UnitedHealth Group Incorporated's (UNH) planned benchmark
offering of senior
unsecured notes in a mix of 10 and 30 year maturities. Fitch
expects the
issuance to be between $1.0 billion and $1.5 billion. The
ratings are equivalent
to Fitch's ratings on UNH's outstanding senior unsecured notes.
UNH's 'A' Issuer
Default Rating (IDR) Outlook is currently Ne
Read more
BRIEF-EnteroMedics says Commercial Patient Data confirms success of co's vBloc therapy in combination with vBloc achieve program
* Commercial Patient Data confirms success of EnteroMedics'
vBloc therapy in combination with vBloc achieve program in
patients struggling to lose weight
Source text for Eikon:
Further company coverage:
Read more
vBloc therapy in combination with vBloc achieve program in
patients struggling to lose weight
Source text for Eikon:
Further company coverage:
Read more
EU lawmakers urge Germany to broaden access to thalidomide fund
STRASBOURG, Dec 15 (Reuters) - EU lawmakers urged Germany on
Thursday to grant broader access for other Europeans to its fund
for thalidomide victims and for the drug's manufacturer to
provide proper compensation and care to victims not yet
recognised.
Read more
Thursday to grant broader access for other Europeans to its fund
for thalidomide victims and for the drug's manufacturer to
provide proper compensation and care to victims not yet
recognised.
Read more
BRIEF-Knight Therapeutics announces exclusive license agreement with AstraZeneca
* Knight therapeutics- as per agreement, co will be
responsible for all commercial, regulatory, certain supply chain
activities for movantik in canada, israel
Read more
responsible for all commercial, regulatory, certain supply chain
activities for movantik in canada, israel
Read more
BRIEF-NOXXON Pharma signs clinical immuno-oncology collaboration agreement with MSD to study NOX-A12 combined with Keytruda (Pembrolizumab) in pancreatic and colorectal cancer
* Two companies will collaborate in a Phase 1/2 clinical trial of NOXXON's ANTI-CXCL12
agent, NOX-A12, and MSD's anti-PD-1 inhibitor, Keytruda (Pembrolizumab)
Read more
agent, NOX-A12, and MSD's anti-PD-1 inhibitor, Keytruda (Pembrolizumab)
Read more
UPDATE 1-Philips, Infineon lose appeal against EU cartel fines
LUXEMBOURG, Dec 15 (Reuters) - Philips and Infineon
lost an appeal on Thursday against a combined 102.9
million euro ($107.8 million) cartel fine after a European court
said EU antitrust regulators was correct to find they had fixed
prices of smart card chips.
Read more
lost an appeal on Thursday against a combined 102.9
million euro ($107.8 million) cartel fine after a European court
said EU antitrust regulators was correct to find they had fixed
prices of smart card chips.
Read more
BRIEF-Top Glove Corporation Bhd seeks trading halt
* Top glove corporation seeks trading halt pending co's
quarterly report on consolidated results for financial period
ended 30 Nov 2016.
Source text for Eikon:
Further company coverage:
Read more
quarterly report on consolidated results for financial period
ended 30 Nov 2016.
Source text for Eikon:
Further company coverage:
Read more
EU court dismisses Philips, Infineon action against cartel fine
LUXEMBOURG, Dec 15 (Reuters) - An EU court on Thursday
dismissed an appeal brought by Philips and Infineon
against a fine imposed on by the European Commission
for operating a cartel to manipulate prices for smart card
chips.
Read more
dismissed an appeal brought by Philips and Infineon
against a fine imposed on by the European Commission
for operating a cartel to manipulate prices for smart card
chips.
Read more
Spain's Grifols plans to refinance debt in Q1 2017 after Hologic buy
MADRID, Dec 15 (Reuters) - Spain's Grifols, which
on Wednesday said it would buy U.S. Hologic Inc's
assets in their blood screening joint venture, will refinance
its net debt in the first quarter of next year, its Chief
Financing Officer said on Thursday.
Read more
on Wednesday said it would buy U.S. Hologic Inc's
assets in their blood screening joint venture, will refinance
its net debt in the first quarter of next year, its Chief
Financing Officer said on Thursday.
Read more
BRIEF-Chiome Bioscience announces exercise of options
* Says 1,890 units of its 13th series options were exercised
to 1.89 million shares of its common stock from Dec. 6 to Dec.
15
Read more
to 1.89 million shares of its common stock from Dec. 6 to Dec.
15
Read more
Wednesday, December 14, 2016
German stocks - Factors to watch on December 15
FRANKFURT, Dec 15 (Reuters) - The DAX top-30 index
looked set to open 0.2 percent higher on Thursday, according to
premarket data from brokerage Lang & Schwarz at 0708 GMT.
Read more
looked set to open 0.2 percent higher on Thursday, according to
premarket data from brokerage Lang & Schwarz at 0708 GMT.
Read more
BRIEF-Scandidos Q2 EBITDA loss widens to SEK 1.3 million
* Q2 net sales 11.3 million Swedish crowns ($1.2 million)
versus 10.4 million crowns year ago
Read more
versus 10.4 million crowns year ago
Read more
BRIEF-Takara Bio signs exclusive license agreement of Oncolytic virus HF10 with Otsuka Pharmaceutical
* Says it signed an exclusive license agreement of Oncolytic
virus HF10 with Otsuka Pharmaceutical
Read more
virus HF10 with Otsuka Pharmaceutical
Read more
BRIEF-Takara Bio unit to buy Rubicon Genomics
* Says its unit Takara Bio USA Holdings Inc plans to acquire
Rubicon Genomics, Inc in early Jan. 2017
Read more
Rubicon Genomics, Inc in early Jan. 2017
Read more
Japan's Fujifilm to announce acquisition at 0600 GMT
TOKYO, Dec 15 (Reuters) - Japan's Fujifilm Holdings Corp
said it will hold a press conference at 0600 GMT on
Thursday in Tokyo to announce a planned acquisition.
Read more
said it will hold a press conference at 0600 GMT on
Thursday in Tokyo to announce a planned acquisition.
Read more
BRIEF-Top Glove Corporation says qtrly profit attributable is 73.3 mln RGT
* Qtrly profit attributable 73.3 million rgt vs 128.3
million rgt; qtrly revenue 785.6 million rgt vs 800.3 million
rgt
Read more
million rgt; qtrly revenue 785.6 million rgt vs 800.3 million
rgt
Read more
BRIEF-I'rom Group buys 61 pct stake in CMAX Clinical Research
* Says it acquired 61 percent stake in CMAX Clinical
Research Pty Ltd from IDT Australia Limited for AU$10 million
Read more
Research Pty Ltd from IDT Australia Limited for AU$10 million
Read more
BRIEF-Meganesuper and Alcon Japan to buy MEGANE HOUSE for 300 mln yen
* Says the co and Alcon Japan Ltd to buy MEGANE HOUSE CO.LTD
for 300 million yen on Jan. 31, 2017
Read more
for 300 million yen on Jan. 31, 2017
Read more
MIDEAST STOCKS - Factors to watch - Dec 15
Dec 15 (Reuters) - Here are some factors that may affect
Middle East stock markets on Thursday. Reuters has not verified
the press reports and does not vouch for their accuracy.
Read more
Middle East stock markets on Thursday. Reuters has not verified
the press reports and does not vouch for their accuracy.
Read more
PRESS DIGEST- Financial Times - Dec 15
Dec 15 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Subscribe to:
Posts (Atom)